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Abstract 
BACKGROUND: The human brain relies on sufficient glucose supply for function. 
The optimal function of neurons depends on the support of astrocytes. Glucose 
deficiency may lead to irreversible neuronal cell damage. How glucose deprivation 
affects the survival and neurotrophic properties of glial cells is not well understood. 
HYPOTHESIS: Glucose deficiency alters the survival and neurotrophic properties of 
glial cells. MATERIALS and METHODS: C6 glioma cells and primary astrocytes 
were incubated with 1, 2 and 3 mM of glucose. Cell growth was determined by direct 
cell count, ^H-thymidine incorporation and flow cytometry assays. Neurotrophic 
properties were determined by the expressions of brain-derived neurotrophic factors 
(BDNF), nerve growth factor (NGF), neurotrophin-3 (NT-3)， 
neurotrophin-4/5(NT-4/5), SIOOB as well as genes involved in lipid homeostasis. 
Changes of cellular lipid profiles, including media and cellular cholesterol and fatty 
acids, were analyzed by gas chromatography (GC) and GC-mass spectrometer 
(GC-MS). RESULTS: When glucose concentration decreased from 3 mM to 1 mM, 
the following results were obtained. (1) Shortened population doubling time with a 
significant decrease of saturation density without the induction of apoptosis in C6 
cells. (2) Expression of neurotrophic factors, NGF, BDNF, NT-3 and SIOOB 
changed in a cell type-specific manner, while mRNA expression of NT-4/5 was 
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up-regulated in both astrocytes and C6 cells. (3) Up-regulation of apolipoprotein E 
(ApoE) and fatty acid synthase (FASN) and down-regulation of mitochondrial 
3-hydroxy-3-methylglutaryl-coenzyme synthase (HMGCS2) mRNA expression in 
C6 cells and primary astrocytes were detected. 3-hydroxy-3-methylglutaryl-CoA 
(HMG-CoA) reductase and cytosol 3-hydroxy-3- methylglutaryl-coenzyme synthase 
(HMGCSl) in C6 cells were up-regulated. Down-regulation of HMGCSl in the 
primary astrocytes was detected. (4) Significant increase in the amount of media 
and cellular cholesterol and fatty acids were seen in C6 cells but not in astrocytes. 
Nevertheless, changes of the media and cellular fatty acid profiles were observed in 
both cell types. CONCLUSION: Glucose deficiency does not cause an overall 
down-regulation of cell proliferation or the secretion of neurotrophic factors. 
Instead, glial cells modify their neurotrophic strategies in a pathway and 
gene-specific manner in response to glucose deficiency by switching the lipid and 
neurotrophic factor expression profiles. Whether such changes convey 








膠質腫瘤細胞與原代大鼠星狀神經膠質細胞培育在含有1 mM，2 mM或3 mM的 
葡萄糖的培育液內。運用直接計算細胞數量、超重氫胸腺喷淀摻入法及流式水 
平細胞先度方法來測量細胞增殖量。此外，也測驗了神經成長因子（NGF)、腦 
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Chapter 1 Introduction 
1.1 General Introduction 
Glucose is the dominant substrate for the mammalian brain energy metabolism 
(Vannucci et al., 1997; Duelli and Kuschinsky，2001). Although a mature human 
brain only accounts for 2% of the total body weight, it consumes up to 25% of the 
total glucose supply of the body (Guzman and Blazquez, 2001). After glucose 
enters the brain, it is either phosphorylated irreversibly to glucose-6-phosphate and 
metabolized in the pentose phosphate shunt or in the Embden-Meyerhoff pathway, or 
converted to glycogen for storage. The pentose phosphate shunt is important for 
nucleic acid synthesis, the Embden-Meyerhoff pathway permits glycolytic 
conversion of glucose to pyruvate and glycogen synthesis provides a source of fuel 
under metabolic stress (Pascual et al.’ 2004). The availability of glucose is 
therefore a critical factor for the metabolic activities of the brain. 
When blood glucose level decreases from normal physiological value (5 mM) to 
only half of the normal value (2 to 3 mM), cognitive impairment results (Lincoln et 
al., 1996). Furthermore, if blood glucose level falls below 1 mM, mental confusion 
and coma occur (Carroll et al, 2003). Although other energy substrates, such as 
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pyruvate, lactate and propionate, can be used by the brain, evidence showed that cells 
using glucose as their primary energy source are less susceptible to stress and 
harmful conditions (Malhotra and Brosius，1999). 
Decreased cerebral glucose levels causes failure in brain functioning, which 
includes impaired synaptic transmission (Ikemoto et al., 2003)，depletion of 
high-energy phosphate compounds (Kahlert and Reiser, 2004), declined cerebral 
oxygen supply (Richardson et al., 1985)，depressed glucose metabolism (loudina et 
al., 2004)，membrane depolarization due to failure of the Na+/K+ATPase pump and 
redistribution of ions across cell membrane (Fung et aL, 1999; Anderson et al., 2000)， 
extracellular accumulation of excitatory amino acids (Delgado-Esteban, 2002), 
excitotoxic calcium overload (Kahlert and Reiser, 2004), accumulation of 
arachidonic acid (AA) in brain tissue (Agardh et aL, 1980) and decrease in cerebral 
protein synthesis (Kiessling et aL, 1984). In recent years, conditions of several 
diseases have been associated with decreased brain glucose concentration, such as 
the glucose transporter type 1 deficiency syndrome (GlutlDS) (De Vivo et al., 1991), 
diabetes mellitus (DM) (McCall, 2004), and Alzheimer disease (Kalaria and Harik， 
1989). However, the mechanisms of how impaired glucose supply affects the 
development of these diseases are unclear. 
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1.2 Nervous System and the Blood-Brain-Barrier 
The central nervous system (CNS) consists of two types of cells: neurons and 
glial cells. Neurons are responsible for recording and distributing information using 
electrical and chemical transmission. Glial cells are responsible for the proper 
functioning of neurons. There are about 100 billions of neurons and 10 to 50 times 
more glial cells relative to neurons in the human brain (Kandel et aL, 2000). The 
CNS is separated from the peripheral circulation system by the blood-brain-barrier 
(BBB) which is located at the specialized endothelial cells of the brain capillaries 
which are around 50 to a 100 times tighter than peripheral microvessels (Abott， 
2002). This barrier provides static and dynamic properties for the brain by strictly 
controlling the entry of various molecules (Kacem et aL, 1998). These properties 
are critical for protecting the brain from toxic molecules and providing optimal 
environment for brain functioning (Laterra et al.’ 1993; Fishman，1992). 
1.3 Glial cells 
Glial cells are mainly divided into two groups. They are macroglial cells and 
microglial cells. Macroglial cells include oligodendrocytes and astrocytes. They 
are derived embryologically from ectodermal precursors within the nervous system. 
Microglials are derived from bone marrow monocyte precursors as their counterparts 
3 -
in the hematopoietic system and they share common features with immune cells 
(Kaur et al., 2001). Traditionally, glial cells were viewed as passive participants in 
the CNS. However, more and more studies indicate that glial cells, especially 
astrocytes, are actually active and able to communicate with neurons (Vesce et al., 
1999; Kaur et al, 2001). 
1.4 Studying Astrocyte Responses as a New Direction in Neuroscience 
Both acute and chronic injuries of the brain cause neuronal cell death (Siman et 
al., 2004). Understanding the molecular mechanisms of neuronal cell death will help 
the development of new treatments for reverting or slowing down the progression of 
brain damages. Many evidences showed that astrocytes are more resistant to stress 
than neurons (Sheline et al., 2004 ； Brown, 1999; Shih, 2003; Almeida et al., 2002)， 
and co-culture of astrocytes with neurons can protect the neurons from death induced 
by toxins and metabolic impairments (Vibulsreth et al 1987; Park et al, 2001; Chen 
et al., 2001). It was later found that astrocytes protect neuronal cell death by 
secreting various neurotrophic factors (Obara and Nakahata, 2002). Furthermore, in 
the last decade, it was found that glial cells not only support the neuronal cell 
survival, but also are responsible for controlling the synapse formation and 
transmission efficacy of neurons (Pfrieger and Barres, 1997; Ullian et al., 2001). 
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As the roles of astrocytes are complicated and important for optimal function of 
brains, understanding the responses of glial cells in normal and pathological 
conditions has become a new approach for controlling neuronal death (Obara and 
Nakahata, 2002). 
1.5 The Roles of Astrocyte in the CNS 
Astrocytes constitute the largest glial cell population in the brain (Bachoo et al., 
2004; Levison et al” 1993). They are polyhedron in shape and enriched with glial 
fibrillary acidic protein (GFAP), giving a star-shape like image when recognized by 
immunolabeling (Bushong et al., 2002). The important roles played by astrocytes 
in the CNS are reflected by the proportion of astrocytes to neuronal cells. The ratio 
of astrocyte to neuron increases dramatically with brain complexity (Figure 1.1) 
(Bass et al., 1971). The increasing quantities of astrocytes with evolution may 
correspond to increasingly dense and sophisticated communication in the CNS that 
requires higher local modulation and control. 
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Figure 1.1 Relative ratios of astrocytes to neurons in different species of animals 
(adopted from Newman, 2003). 
Anatomically, astrocytes enwrap the vasculature with end-feet at the vessel of 
endothelial cells of the blood-brain-barrier (BBB) (Hamm et al.，2004). Astrocytes 
secrete several factors, such as transforming growth factor B (TGF-B) and 
glial-derived neurotrophic factors for the induction and the maintenance of the BBB. 
The anatomical orientation of astrocytes around the vessels enables them to act as the 
main suppliers of nutrients to the neurons (Tran et al, 1999). Other properties of 
astrocytes include regulating and optimizing the environment for neuronal functions, 
such as glucose transport, maintaining local ion and pH homeostasis, metabolic 
substrates supplies and clearance of toxic neuronal waste and neurotransmitters 
(Auld and Robitaille, 2003). Furthermore, astrocytes regulate synaptic transmission 
and synaptogenesis, establish the functional and structural architecture of the adult 
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brain, regulate and judge neuronal behaviors and activities and are even able to 
develop into neurons (Nedergaard et al., 2003). Therefore, dysregulation of these 
functions is implicated in the pathogenesis of numerous neurodegenerative diseases 
(Maragakis and Rothstein，2001; Auld and Robitaille, 2003; Fukamachi et al., 2001). 
1.5.1 Energy-Dependent Communication between Neurons and Astrocytes 
Astrocytes communicate with neurons via neurotransmitter receptors and 
neuromodulators. Two types of astrocytic Ca^^ signaling have been found, Ca^^ 
oscillations and Ca^^ waves (Araque et al., 1998). Neurotransmitters released from 
presynaptic neurons activate adjacent glial cells by increasing intracellular Ca^^. 
The glial cells are activated by releasing transmitters like glutamate and ATP. The 
signal generated would feedback into the presynaptic terminal or directly stimulate 
postsynaptic neurons to regulate synaptic transmission (Newman, 2003). 
Astrocytes also communicate with adjacent astrocytes through gap junctions and 
extracellular ATP. Since all these cellular communication mechanisms are 
energy-dependent, they can only be sustained when sufficient energy metabolites are 
available (Deitmer, 2001). 
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1.5.2 Strategies for Metabolic Exchange Between Astrocytes and Neurons 
Neurons and astrocytes are densely packed in the brain to increase 
communication efficiency. The metabolic energy supply system and signal 
metabolite transfer cooperate with each other (Deitmer, 2001). During signal 
transmission, neurons release signaling molecules that target to neurons and the 
surrounding astrocytes (Anderson and Swanson, 2000). The neurotransmitters and 
cofactors released by neurons also reach the surrounding glia. Glia are thus 
activated via ionotrophic and metabotropic receptors and the changes of intracellular 
Ca2+ and Na+ concentrations follows (Steinhauser and Gallo，1996). The changes of 
intracellular ion concentration then activates enzymes and ion channels in cells 
triggering the subsequent cellular events, such as glucose uptake, glycolysis and 
glycogenolysis that serves as an extra energy metabolite supply in stress conditions 
(Figure 1.2) (Pellerin and Magistretti, 1994). Astrocytic transport systems that 
involve clearing of neurotransmitter will also be activated. Other than 
neurotransmitters, astrocytes can also be stimulated by ions, osomolytes and 
metabolites. 
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Figure 1.2 Schematic illustration of the mechanism for glutamate-induced 
glycolysis in astrocytes during physiological activation (Modified from Pellerin 
and Magistretti, 1994). During signal transduction at the synapse, glutamate is 
released into synaptic cleft and bind to the receptors on postsynaptic membrane and 
on astrocytes. Activation of astrocytes by glutamate initiates a serial activation of 
enzyme and transporters. Finally, glucose uptake and glycolysis are promoted. 
Details refer to 1.5.2.4. 
1.5.2.1 Provision of Energy Metabolites to Neurons by Astrocytes 
The brain is one of the most metabolically active organs in the body (Sokoloff， 
1973). Although it constitutes only 2% of body weight, it accounts for up to 20% 
of the total body basal oxygen consumption and 25% of glucose supply, with CO2 
production over O2 consumption ratio 1.0，and O2 consumption/glucose ratio at 
approximately 5.5. These ratios are close to the complete oxidation of carbohydrates. 
These data support that glucose is the dominant energy metabolite for the ATP 
production in the brain (Pellerin and Magistretti, 2003; Guzman and Blazquez, 2001). 
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Transportation of glucose across the BBB and the uptake into glial cells and neural 
cells are facilitated by the glucose transporter proteins (Vannucci, 1997). Other 
substrates, such as lactate, pyruvate and ketone bodies may also serve as energy 
metabolites under specific conditions, such as brain development, starvation, 
diabetes and hypoglycemia (Larrabee, 1995; Fernandes et al., 1984; Hellmann et al” 
1982; Vannucci and Simpson, 2003). 
1.5.2.2 Glucose Transporters in the CNS 
Glucose transport across the BBB is dependent on the Glutl protein as it is the 
major glucose transporter found on the luminal and abluminal membranes of the 
brain endothelial cells (Gerhart et al” 1989). Glutl exists in two isoforms with 
molecular weight of 55 kDa and 45 kDa as a result of differential glycosylation 
(McCall et al, 1996; Vannucci et al., 1997). The 55 kDa isoform is found on the 
luminal and the abluminal membranes of the brain endothelial cells at the BBB, 
while the 45 kDa isoform is found in the astrocytes (Duelli et al., 2001; Maher et al” 
1994). 
Other glucose transporters are also found in the brain. Glut3 and GlutS are 
found on neurons (Reagan et aL, 2002; Piroli et aL, 2004), GlutS is a fructose 
transporter imbedded in microglial cells, and Glut4 is detected in the hippocampal 
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pyramidal cell layer (Choeiri et al., 2002). 
Due to the high metabolic demands in the brain, glucose transport across the 
BBB can be the rate-limiting factor for the energy supply to the brain (Pascual et al” 
2004). In normal physiological state, glucose concentration in the circulation is 
about 5 mM. Glucose is transported down the concentration gradient via Glutl into 
the brain endothelial cells where the glucose concentration is around 3 mM. 
Glucose is then further transported down the concentration gradient via Glutl into 
cerebral spinal fluid (CSF) where the glucose concentration is 2.7 mM. Then, 
glucose enters astrocytes via Glutl and enters neuron via Glut3 (Figure 1.3) 
continuously along the concentration gradient. In astrocytes, glucose may be 
converted into other substrates. As a result, a deeper glucose concentration gradient 
across the BBB occurs whenever there is a higher local cerebral glucose utilization 
rate. This also drives a faster glucose transport rate (Duelli and Kuschinsky, 2001). 
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Figure 1.3 Location of the different glucose transporter isoforms in the brain. 
Glutl is abundant in its 55 kDa isoform in the endothelial cells，whereas the 45 kDa 
isoform is expressed in astrocytes. Glut3 is the neuronal glucose transporter. Only 
traces of other Glut isoforms are found in the brain; of these, Glut4 was detected in 
distinct neuronal populations and GlutS in microglia. (Duelli and Kuschinsky, 2001). 
1.5.2.3 The Lactate Shuttle Hypothesis 
Neurons are presumably the major energy consumers in the brain (Sibson, 
1998). Evidence supported that around 90% to 95% of energy is consumed by 
neurons while glial cells only take up around 5% to 10% under normal level of 
activity (Attwell and Laughlin, 2001). However, around 80% of glucose metabolism 
is taking place in glial cells (Pellerin and Magistretti, 2003). Furthermore, neurons 
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do not form glycogen as in the astrocytes. Enzymes in gluconeogenesis and 
glycogenolysis are specific for astrocytes (Wiesinger, 1997). Hence, astrocytes are 
responsible for taking up glucose for glycolysis, storing glucose as glycogen and 
releasing metabolic intermediates to neurons as an energy supply. This relationship 
is called astrocyte-neuron lactate shuttle hypothesis (Figure 1.4) (Chih et al, 2001). 
During glycolysis, glucose is metabolized to pyruvate, giving two net ATP. 
Pyruvate can be reversibly converted to lactate by the enzyme lactate dehydrogenase 
5 (LDH-5) in astrocytes under aerobic conditions. Lactate molecule is transported 
across the glia via monocarboxylate transporter 1 (MCT-1), and across neurons via 
MCT-2. Proton that is cotransported with lactate will modulate the electrical 
activity of neurons (Deitmer and Rose, 1996). In neurons, lactate is converted into 
pyruvate by LDH-1 and enters the tricarboxylic cycle, eventually producing 34 ATPs 
from each lactate molecule (Chih et al., 2001). Lactate delivered by astrocytes to 
neurons is believed to be the main energetic compound in the mammalian brain 
(Dringen et al, 1993). 
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Figure 1.4 Scheme of energy production in brain cells. Glucose undergoes 
glycolysis in astrocytes to form pyruvate (adapted from Deitmer，2001). 
1.5.2.4 The Regulation of Glucose Uptake at the Blood-Brain-Barrier (BBB) 
by the Activity of Neurons 
Constant removal of neurotransmitters at synapse by astrocytes is important to 
prevent excitotoxicity (Swanson et al” 2004). After entering the astrocytes, 
glutamate can be converted to glutamine by glutamine synthetase and returns to 
neurons for reuse or re-entering into the tricarboxylic cycle to generate ATP (Sibson 
et al. 1998; Deitmer, 2001). Each glutamate molecule is cotransported with three 
sodium ions and one proton into astrocytes, causing the increase of sodium ions in 
the astrocytes. The sodium ions are then removed by either sodium bicarbonate 
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cotransporter or active Na+/K+ pump. The proton is removed by co-transportation 
with lactate via MCTs. As a result, whenever an astrocyte takes up glutamate, it 
stimulates the lactate removal and ATP utilization in the same cell (Zerangue and 
Kavanaugh, 1996). Meanwhile, the decrease of lactate and ATP amounts in 
astrocytes will lead to an up-regulation of glycolysis and eventually an increase in 
glucose uptake at the BBB (Figure 1.2) (Deitmer, 2001). 
1.5.3 Alternation of Energy Metabolism in Neuropathy 
When the brain is under glucose deficiency for a certain period of time, it will 
slowly adapt to use other energy sources, such as ketone bodies, lactate and fatty 
acids (McCall，1993; Vannucci and Simpson, 2003). However，the number of 
transporters of these molecules at the BBB is limited (McCall, 1993). Thus the 
biosynthesis of these molecules from glucose is of almost important. 
1.5.3.1 Ketone Body Shuttle Hypothesis 
Evidence supports that the brain is flexible in using ketone bodies, such as 
D(-)- (3-hydroxybutyrate and acetoacetate, to substitute glucose when glucose 
becomes scarce (Sokoloff, 1973). Ketone bodies are byproducts of fatty acid 
metabolism and present at low concentrations in normal physiological state. 
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However, when blood glucose concentration becomes too low to fullfil the brain's 
energy requirement, such as severe starvation and lactation, the brain can extract and 
utilize ketone bodies from the blood transported by facilitated monocarboxylate 
transporters (Gerhart et al., 1997). The utilization of ketone bodies in the newborn 
mammalian brain is more significant because of the newborn is slightly 
hypoglycemic resulting from the high-fat content of maternal milk (Maurer et al., 
2004). 
Recent evidence showed that ketone body supply for brain functioning is mainly 
provided from astrocytes rather than from the liver. The major pathway for the 
generation of fatty acid-derived ketone bodies is the 
3-hydroxy-3-methylglutaryl-CoA (HMG-CoA) cycle, which is driven by the three 
mitochondrially located enzymes: acetoacetyl-CoA thiolase, mitochondrial 
HMG-CoA synthase (HMGCS2) and HMG-CoA lyase. This cycle affects the 
conversion of acetyl-CoA to acetoacetate, part of which can be converted to the 
alternative ketone body 3-hydroxybutyrate by 3-hydroxybutyrate dehydrogenase 
(Cullingford et al., 1998). The differential ketogenic capacities of organs are 
associated with the levels of HMGCS2 mRNA and the protein, which is proposed to 
be a major regulatory step in fatty acid-derived ketogenesis (Quant et al., 1991). 
Astrocytic ketogenesis is activated by glutamate released from neurons during 
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synaptic activity (Manuel et al 2001). It is possible that astrocytic ketone bodies 
might be used as substrates for neuronal oxidative metabolism together with lactate 
(Guzman and Blazquez, 2001). 
1.5.3.2 The Utilization of Free Fatty Acids by the Brain 
Certain regions of the brain are able to metabolize fatty acids (Evans et al, 
1998). The major saturated and monounsaturated fatty acids in brain lipids are 
exclusively produced locally by de novo biosynthesis (Edmond et al, 1998; Edmond, 
1992). In fact, very little fatty acids can be transported across the BBB due to 
limited transporters. Only essential fatty acids, n-6 and n-3 members of 
polyunsaturated fatty acids (PUFA) (Bezard et al, 1994), are readily transported 
across the BBB via a selective transport system. Essential fatty acids including AA, 
alpha-linolenic acid, eicosapentanoic acid and linoleic acid can be transported across 
the BBB and are critical for synaptic functions and formation (Bezard et al., 1994). 
1.5.4 The Provision of Neurotrophic Factors to Neurons by Astrocytes 
Apart from maintaining energy supply to neurons and regulating the 
microenvironment for optimal neuronal functions, glial cells secrete neurotrophic 
factors that determine the fate of neurons (Obara and Nakahata, 2002; Medina and 
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Tabernero, 2002). As neurons stop proliferating after differentiation, neurotrophic 
factors become essential for neuronal functioning. Neurotrophic factors can also 
help damaged neurons to regenerate their processes in vitro (Marzella and Gillespie, 
2002) and in animal models (Eagle et al” 1995). Because of the possibilities for 
reversing devastating brain disorders, neurotrophic factors have become a new 
therapeutic target (Olson et al., 1994). 
Today, various neurotrophic factors have been identified, such as neurotrophins, 
cytokines, growth factors, protease or protease inhibitors, calcium binding proteins, 
and bone morphogenetic protein. Some are produced and secreted in a cell-type 
specific manner (Obra and Nakahata, 2002). Amongst the neurotrophic factors, 
neurotrophins are the most well-studied protein family because of their widespread 
expression in most neuronal cells (Lessmann et al., 2003). 
1.5.4.1 Neurotrophins 
Neurotrophins are important for regulating neuronal survival, development, 
functioning, and plasticity (Korsching, 1993; Eide et al, 1993; Sofroniew et al., 
2001). Four neurotrophins have been identified in mammals: nerve growth factor 
(NGF), brain-derived neurotrophic factor (BDNF), neurotrophin-3 (NT-3), and 
neurotrophin-4/5 (NT-4/5 (Hallbook, 1999). All neurotrophins are produced as 
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pre-pro-neurotrophin precursors with 240 to 260 amino acids. These newly 
synthesized proteins are transported towards endoplasmic reticulum (ER) directed by 
the signal peptide and attached to ribosomes. The signal peptide is cleaved off 
immediately after the polypeptide chain is sequestered into the ER forming 
pro-neurotrophins. The pro-neurotrophins can form homodimers or heterodimers 
directly in the ER via non-covalent linkages (Merighi, 2002). Pro-neurotrophins 
can be converted to mature neurotrophins by cleaving the pro-domain. Monomeric 
mature neurotrophins weight about 13 kDa while the active dimmer form is about 
27kDa. Both the pro-neurotrophin or neurotrophin dimmers are then packed in 
secretory granules and released into intercellular space independent of Ca^^ elevation, 
or are packed in large dense core vesicles and released into intercellular space in a 
strictly Ca^ "^ - dependent manner (Lessmann et al., 2003). 
Mature neurotrophins secreted into extracellular space would interact with two 
receptors located on cell membrane, p75 neurotrophin receptor (p75 NTR) and 
tyrosine receptor tyrosine kinases receptor (TrkR). Different neurotrophins have 
different affinities towards the receptors. All pro-neurotrophins and mature 
neurotrophins can bind to p75NTR but with different kinetics (Rodriguez-Tebar et al, 
1991). On the other hand, Trk receptors exhibit ligand selectivity. Mature NGF 
selectively bind to Trk A, BDNF and NT-4/5 to Trk B and NT-3 to Trk C (Ip et al, 
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1993). Different ligands binding on different receptors initiate different signaling 
(Atwal, 2000). Many studies showed that neurotrophin-p75NTR interaction is 
critical to govern the fate of neuronal and nonneuronal cells, apoptosis or survival 
(Huang et al, 2001). Trk activation initiates its survival to apoptosis signaling 
through recruiting signaling enzymes and adaptor proteins to the receptor forming 
receptor-adaptor-enzyme complexes that ultimately mediate the trophic effect of 
neurotrophins (Teng and Hempstead, 2004). In fact, neurotrophic factors can 
provide protective effects to neurons or potentiate neuronal death, and these are 
determined by multiple factors, such as insult types, timing and treatments (Koh et 
al, 1995). 
1.5.4.1.1 Relationship Between Neurotrophins and Glucose 
Neurotrophins modulate glucose metabolism in the brain (Skaper and Varon, 
1979). It was demonstrated that BDNF increases glucose utilization and the 
expression of the neuronal glucose transporter, Glut3 (Burkhalter et al., 2003). The 
stimulation of glucose utilization by BDNF is resulted from the activation of 
Na+/K+-ATPase via an increase in Na+ influx mediated by the stimulation of 
Na+-dependent amino acid transport (Brookes, 1988). The pretreatment of the 
neuronal culture with 50ng/ml NGF provides neuroprotective effects to 
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oxygen-glucose deprivation insult (Takman et al., 2004). According to a previous 
report, in case of brain insult initiated by oxygen-glucose deprivation, NT-4/5 
potentiates necrotic neuronal death but prevent apoptotic neuronal death (Lobner and 
Lai, 2002). Endogenous NT-3 was found to promote neuronal cell death induced in 
oxygen-glucose deprivation state that might be due to increased oxygen-radical 
(Bates et al., 2002). 
1.5.4.2 SIOOB 
SIOOB is produced primarily by astrocytes and exerts autocrine and paracrine 
effects on neurons and glia (Van Eldik and Zimmer, 1987; Rothermundt, 2003). In 
vitro studies indicated that intracellular SIOOB affects cell growth, cell structure, 
energy metabolism and calcium homeostasis and exerts protective effects. 
Extracellular SIOOB might be involved in glia-to-neuron signaling and exerts 
neurotrophic effect in nanomolar concentrations. The trophic effects include 
stimulating neurite outgrowth and enhancing neuronal survival during development 
at nanomolar concentrations (Van Eldik et al., 1991). Also, SIOOB at nanomolar 
concentrations decrease death rate and loss of mitochondrial functions in 
hippocampal neurons resulting from glucose deprivation (Barger et al.’ 1995). 
Exogenous SIOOB dimmers will induce signal transduation events by increasing 
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intracellular free calcium concentration in both neurons and glia to provide trophic 
effects (Rothermundt et al., 2003). 
However, this protein has its dark side. Extracellular SIOOB stimulates the 
expression of proinflammatory cytokines in microglia (Adami et al.’ 2001) and 
induces apoptosis at micromolar levels in neurons (Mariggio et al., 1994). In 
animal studies, changes in cerebral SIOOB concentration cause cognitive 
disturbances (Rothermundt et aL, 2003). Transgenic mice studies showed that 
over-expression of human SIOOB impaired hippocampal LTP and spatial learning 
(Gerlai et aL, 1995). In clinical studies, enhanced SIOOB concentration in 
cerebrospinal fluid was observed in cases of brain trauma, ischemia, Alzheimer's 
disease and Down's syndromes (Peskind et aL, 2001). 
1.5.5 Astrocytic Cholesterol in Astrocytes as a Neurotrophic Factor 
Although the brain accounts for only 2% of body weight, it contains 23% of the 
unesterified cholesterol of the whole body pool (Dietschy and Turley, 2004). 
Cholesterol is largely present in the plasma membranes of glial cells and neurons 
(Spector and Yorek, 1985; Bastiaanse et aL, 1997). Apart from serving as a 
component of neuronal cells membrane (Yeagle, 1985)，cholesterol promotes synapse 
formation. It was reported that addition of cholesterol to cultured neurons strongly 
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enhanced the synapse number (Mauch et al., 2001). However, how cholesterol 
promotes synapse formation is still unknown. 
Since cholesterol synthesis is several folds higher in glial cells than in neurons 
(Pfrieger，2003), it was hypothesized that cholesterol must be imported to neurons 
from astrocytes (Goritz et al, 2002). The cholesterol carried by astrocytic 
apolipoprotein E (ApoE) was recognized as an important factor for the promotion of 
synaptogenesis in the CNS (Hayashi et al., 2004). The cholesterol level in neurons 
is tightly controlled. All cholesterol in the CNS is synthesized from glucose via 
acetyl-CoA (Edmond et al” 1991; Jurevics and Morell, 1995). During the 
embryonic stage before astrocytes differentiation, neurons cover their cholesterol 
requirements by local synthesis. After birth, neurons reduce cholesterol synthesis 
and rely on the import from astrocytes by lipid carriers. Glia derived 
ApoE-containing cholesterol mediate endocytosis by low-density lipoprotein 
receptors on neurons while excessive cholesterol is disposed via ATP-binding 
cassette transporter onto lipoproteins with apolipoprotein A l or released in the form 
of oxysterols (Pfrieger, 2003). 
1.6 Neuroprotective Effect of Glucose 
Glucose not only serves as an energy supply to the brain cells, it also prevents 
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neuronal cell death from toxicity. For example, reports have shown that the 
presence of glucose reduces neuronal cell death induced by 
l-methyl-4-phenylpyridinium (MPP+) (Chalmer-Redman et al., 1999) and 
glutamate-mediated neurotoxicity (Delgado-Esteban et al., 2000). On the other 
hand, in vitro study showed that glucose deprivation induces mitochondrial 
dysfunction and oxidative stress in neurons (Almeida et al., 2002). 
1.7 Diseases Associated with Decreased Glucose Transport at the BBB 
1.7.1 Glucose Transporter Type 1 Deficiency Syndrome (GlutlDS) 
The identification of Glutl DS proves the principle that glucose transport across 
the BBB is a rate-limiting step for energy metabolism in the brain (De Vivo et al., 
1991). GlutlDS patients show a 50% lower CSF/blood glucose concentration than 
normal. Symptoms of GlutlDS include infantile seizures, delays of mental 
development, microcephaly, ataxia, and spasticity. 
1.7.2 Hypoglycemia with Insulin Therapy for Diabetes Patients 
Diabetes mellitus (DM) is a disorder caused by a relative (Type 2 DM) or 
absolute deficiency (Type 1 DM) of insulin. Type 1 diabetic (insulin-dependent) 
patients have to rely on insulin injection for survival. However, this may lead to a 
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situation called hypoglycemia unawareness in which the patient cannot recognize 
hypoglycemia at an early stage that permits self-treatment (Hirst, 2004). This 
becomes a major side effect of the therapy of type 1 DM. In fact, hypoglycemia 
occurs very frequently in these patients (Arias et al., 1985), which may cause a lack 
of concentration, disruption of cognitive functions, convulsions and unconsciousness 
(Mohseni，2001). Reports also showed that insulin therapy for DM treatment might 
cause brain damage and even death due to hypoglycemia (Tattersall and Gill, 1991). 
Prolonged hypoglycemia will limit glucose transport at the BBB causing glucose 
deficiency in the brain and alter the concentrations of many metabolites of glucose 
such as arachidonate，acetylcholine, aspartate and glutamate (McCall, 1993). 
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1.8 Aims and Hypothesis of Study 
The activity of the brain is dependent on the sufficient and continuous supply of 
glucose from the circulation to the CNS. Glucose supply has been proved to be one 
of the limiting factors for energy metabolism in the CNS since the discovery of 
GlutlDS. Glucose deficiency not only limits the energy supply for cell metabolism, 
but also limits the supply of substrates for DNA synthesis and lipid synthesis in the 
brain. Therefore，glucose deficiency is a stressful condition for the CNS and should 
induce changes of glial cell response. 
The hypothesis of this project: 
Glucose deficiency alters the growth and neurotrophic properties including 
neurotrophic factor expressions and lipid homeostasis of glial cells. 
The aims of this project: 
1. To monitor the growth properties of glial cells in different glucose 
concentrations. 
2. To characterize the effect of glucose deficiency on the expression of 
neurotrophic factors and lipid homeostasis. 
3. To characterize the effect of glucose deficiency on lipid homeostasis. 
26 -
Chapter 2 Materials and Methods 
2.1 Materials 
2.1.1 Cell Culture 
2.1.1.1 Cells 
2.1.1.1.1 C6 Cells 
The cell line was obtained from Dr. David SC Tsang’ s laboratory 
(Department of Biochemistry, The Chinese University of Hong 
Kong). 
2.1.1.1.2 Primary Astrocytes 
Astrocytes are directly dissected from 2-day old Sprague-Dawley (SD) 
rat obtained from the Laboratory Animal Services Centre at the 
Chinese University of Hong Kong. 
2.1.1.2 Cell Culture Reagents 
1) High Glucose Dulbecco's Modified Eagle's Medium (DMEM) 
13.44 g of the powder of high Glucose Dulbecco's Modified Eagle's 
Medium (DMEM) purchased from Gibco BRL Life Technologies, Inc. 
(Carlsbad，CA, USA) was dissolved in double distilled water 
supplement with 44.05 mM sodium bicarbonate (Sigma, St. Louis, 
MO, USA) and 20 mM 4-(2-Hydroxyethyl)piperazine-l-
27 -
ethanesulfonic acid (HEPES) (Sigma, St. Louis，MO, USA) per liter 
of medium. The pH value of the medium was adjusted to 7.25 by 
2M NaOH (ICN BioMedicals Inc., Irvine, CA，USA) and the medium 
was then sterilized by filtration through 0.22 |im filter (Millipore, 
Billerica, Mass, USA) and stored at 4°C for no more than 30 days. 
2) No Glucose DMEM 
Each liter of no glucose DMEM was prepared by dissolving 8.3g of 
DMEM based powder (without glucose, L-glutamine, L-cystine, 
phenol red, sodium pyruvate and sodium bicarbonate) (USB, 
Swampscott, MA, USA) in double distilled water and supplement 
with 0.201 mM L-cystine, 4 mM of L-glutamine, 0.0399 mM phenol 
red, 44.05 mM sodium bicarbonate (Sigma, St. Louis, MO, USA) and 
20 mM HEPES (Sigma, St. Louis, MO, USA). 
3) Serum Supplements 
Fetal bovine serum (FBS) purchased from Gibco BRL Life 
Technologies, Inc. (Carlsbad, CA, USA) was stored as 50 ml aliquots 
in sterile centrifuge tubes at -20°C. 
4) Antibiotic Mixture Solution 
Penicillin-Streptomycin (PS) antibiotic mixture stock solution 
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containing 10,000 units/ml penicillin G sodium plus 10,000 \iglm\ 
streptomycin sulfate in 0.85% saline was purchased from Gibco BRL 
Life Technologies, Inc. (Carlsbad, CA, USA). It was stored as aliquots 
of 10 ml in sterile centrifuge tubes at -20°C. Each liter of media 
contained 10 ml stock antibiotic solution to give 1% (v/v) antibiotics 
to prevent possible contamination of cell culture. 
5) Complete Medium 
Each liter of complete medium was composed of 89% (v/v) high 
glucose DMEM with 10% (v/v) FBS and 1% (v/v) PS solution. 
Medium was used within 30 days. 
6) 2M glucose solution 
The solution was prepared by dissolving 9.9g of glucose (C6H12O6. 
H2O) (Sigma, St. Louis, MO, USA) powder in 50ml of double 
distilled water and stored at -80°C as aliquots of 5 ml. 
7) Assay Media 
Different glucose concentration media were prepared from no glucose 
DMEM supplement with 1% FBS and addition of different volumes 
of 2M glucose solution. 
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8) Phosphate-Buffered Saline (PBS) 
lOX PBS stock solution was prepared by dissolving 80 g of sodium 
chloride (NaCl) (Sigma, St. Louis, MO, USA), 2 g of potassium 
chloride (KCl) (Sigma，St. Louis, MO, USA)，14.4 g of dibasic 
sodium phosphate (Na2HP04) (Sigma, St. Louis, MO, USA), 2.4 g of 
monobasic potassium phosphate (KH2PO4) (Sigma, St. Louis, MO, 
USA) in double distilled water making up to one liter without pH 
calibration. A working solution of IX PBS was prepared by diluting 
one volume of warmed and well-mixed lOX PBS with nine volumes 
of double distilled water. The pH value was calibrated to 7.4 by 6N 
HCl (Sigma，St. Louis, MO, USA) or 2 M NaOH (ICN BioMedicals 
Inc., Irvine, CA, USA) solution. IX PBS then was sterilized by 
autoclaving at 121°C for 20 minutes. It was stored at 4°C until use. 
9) 0.05% Trypsin-EDTA Solution 
Trypsin-EDTA solution containing 0.05% trypsin and 0.53 mM 
EDTA-4Na in Hanks' balanced salt solution was purchased from 
Gibco BRL Life Technologies, Inc. (Carlsbad, CA, USA). It was 
stored at -20°C as aliquots of 50 ml. 
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10) 0.25% Trypsin-EDTA Solution 
Trypsin-EDTA solution containing 0.25% trypsin and 1 mM 
EDTA-4Na in Hanks' balanced salt solution was purchased from 
Gibco BRL Life Technologies, Inc. (Carlsbad, CA, USA). It was 
stored at -20°C as aliquots of 15 ml. 
11) Cell Culture Wares 
2 
Glasswares used for sub-culture and experiments, including 150 cm 
flasks, 75 cm^ flasks, 60 mm dishes, 100 mm dishes, multi-well plates 
and centrifuge tubes were all purchased from Iwaki (Chiba, Japan). 
2.1.2 Study of Growth Properties 
2.1.2.1 Equipment for Growth Curve Construction 
1) Hemacytometer 
Cell number was determined by direct cell count using 
hemacytometer purchased from Sigma (St. Louis, MO, USA). 
2) Microscope 
Cell counting was performed under a light microscope 
manufactured by Olympus America Inc. (Melville, NY, USA) with a 
magnification 100 X. 
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2.1.2.2 Reagents for Flow Cytometry 
1) Propidium Iodide (pi) DNA Staining Solution 
The pi DNA staining solution containing 8 |Lig/ml ribonuclease A 
(Rnase A) (Roche Applied Science, Indianapolis, IN, USA) and 40 
jig/ml pi (Sigma, St. Louis, MO, USA) was freshly prepared in PBS 
and kept in darkness at 4°C. 
2) FACS Flow Shealth Fluid 
The shealth fluid is a ready-to-use balanced electrolyte solution 
containing sodium chloride, potassium chloride, disodium EDTA, 
sodium fluoride and anti-microbial agent, which was purchased from 
the Becton Dickinson International (Franklin Lakes, NJ，USA) and 
stored at room temperature. 
2.1.2.3 Reagents for ^H-thymidine Incorporation Assay 
1) [methyl-^H] Thymidine (^H-TdR) 
The stock solution (Amersham Biosciences, Buckinghamshire, UK) at 
a concentration of 0.5 nmol/fal (1 |LiCi/|il, 2 Ci/mmol) was kept at 4 � C . 
It was freshly diluted with IX PBS to make up a 0.025 nmol/|Lil 
(0.05^iCi/|Ld) working solution before cell labeling. In cell labeling 
experiment, 0.5 nmol/well (20 \il of working solution/well) was added 
into each well of 24-well plates conatining 1ml of medium to give a 
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final concentration of 0.5 nmol/ml (1 faCi/ml). 
2) Trichloroacetic Acid (TCA) 
TCA used was purchased from ICN BioMedicals Inc. (Irvine, CA, 
USA). 
3) Liquid Scintillation Cocktail 
The OptiPhase 'HiSafe 2, liquid scintillation cocktail was purchased 
from Perkin-Elmer, Inc. (Wellesley, MA, USA) and kept in darkness 
at room temperature. 
2.1.3 Study of Neurotrophic Properties 
2.1.3.1 Determination of Neurotrophic Factor Productions 
2.1.3.1.1 Reagents and Buffers for Northern Blot Analysis 
2.1.3.1.1.1 RNA Extraction 
1) Diethyl Pyrocarbonate (DEPC) 
DEPC was purchased from Amersham Biosciences (Buckinghamshire, 
UK). 
2) DEPC-treated Double Distilled Water (DEPC-Treated Water) 
DEPC was added to double distilled water at 1:1000 ratio to give 
0.1% (v/v) DEPC water and stirred overnight to disperse the DEPC. 
Thereafter, the solution was autoclaved at 121°C for 20 minutes to 
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vaporize the remaining DEPC. The DEPC-treated water was stored at 
room temperature. 
3) TRI Reagent and l-Bromo-3-Chloropropane (BCP) 
They were purchased from Molecular Research Center, Inc. 
(Cincinnati, OH, USA) and kept in brown bottle at room temperature. 
4) Spectrophotometry Cuvette 
The UVette® used for RNA concentration measurement was 
purchased from Eppendorf (Hamburg, Germany). 
2.1.3.1.1.2 Agarose Gel for Electrophoresis of RNA 
1) 1% (w/v) Agarose Gel 
Agarose was purchased from Sigma (St. Louis, MO, USA). 
2) Tris-Borate-EDTA (TBE) Electrophoresis Buffer (5X) 
Stock TBE buffer (5X) was prepared by dissolving 54g of Tris base 
(Amersham Biosciences, Buckinghamshire, UK), 27.5g of boric acid 
(Amersham Biosciences, Buckinghamshire, UK) and 20 ml of 0.5 M 
EDTA (Sigma, St Louis, MO, USA) in double distilled water making 
up to 1 liter with pH calibrated to 8.0 using 6N HCl or 2M NaOH. 
Working solution (IX) was prepared by diluting the stock buffer by 5 
folds using autoclaved double distilled water. Both stock and working 
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solutions were filtered into an autoclaved bottle and kept at room 
temperature. 
3) 1% (w/v) Agarose Gel 
1% agarose gel was prepared by dissolving 1% (w/v) of Agarose 
purchased from Sigma (St. Louis, MO, USA) in IX TBE buffer and 
boil with microwave for 1 minute at 700W. 
4) Gel Loading Solution (6X) 
Loading dye was prepared from 0.25% (w/v) of bromophenol blue 
(Amersham Biosciences, Buckinghamshire, UK), 0.25% (w/v) of 
xylene cyanol FF (ICN BioMedicals Inc, Irvine, CA, USA), and 40% 
of glycerol (Amersham Biosciences, Buckinghamshire, UK) in 
autoclaved double distilled water. Stock was kept as aliquots of 1 ml 
at -20°C. The working dye was stored at 4°C. 
5) Ethidium Bromide (EtBr) Stock 
EtBr was prepared as 10 mg/ml stock solution (Amresco, Ohio，USA) 
and kept in darkness at room temperature. 
6) Electrophoresis Apparatus 
They were purchased from Bio-Rad Laboratories (Hercules, CA, 
USA). 
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2.1.3.1.1.3 Denaturing Agarose Gel for Electrophoresis of RNA 
1) 5M Ethylenediaminetetraacetic add (EDTA) pH 8.0 
Stock 0.5 M EDTA solution was prepared by dissolving 29.224g of 
EDTA (Sigma, St Louis, MO, USA) in double distilled water making 
up to 200 ml with pH calibrated to 8.0 using 2 M NaOH (ICN 
BioMedicals Inc., Irvine, CA，USA) 
2) 3X Formamide-Loading Buffer 
The buffer was prepared as 80% (w/v) of deionized formamide 
(Sigma, St Louis, MO, USA), lOmM EDTA (pH 8.0), 0.25% (w/v) of 
bromophenol blue (Amersham Biosciences, Buckinghamshire, UK), 
0.25% (w/v) of xylene cyanol FF (ICN BioMedicals Inc, Irvine, CA, 
USA). 1 fil of EtBr stock (10 mg/ml) was added per 1 ml of the dye. 
3) 1 M Sodium Acetate 
It was prepared by dissolving 82.03g of sodium acetate (USB, 
Swampscott, MA, USA) in DEPC-treated water making up to 1 liter 
and filtered through 0.22 |j,m filter (Millipore, Billerica, Mass, USA) 
and stored at room temperature. 
4) lOX 3-[N-Morpholino]propanesulfonic Acid (lOX MOPS) 
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Running Buffer 
Stock lOX MOPS was prepared by dissolving 41.8g of MOPS powder 
(USB, Swampscott, MA, USA) in 700 ml of DEPC-treated water and 
pH was adjusted to 7.0 with 2M NaOH (ICN BioMedicals Inc.，Irvine, 
CA, USA), followed by the addition of 20 ml of 1 M sodium acetate 
and 20 ml of 0.5 M EDTA (pH 8.0). Solution was made up to 1 liter 
with double distilled water. Stock solution was then filtered through 
0.22 fim filter (Millipore，Billerica, Mass, USA) and stored at room 
temperature in darkness. 
5) 12.3M Formaldehyde (37%w/v) 
It was purchased from Sigma (St. Louis, MO, USA). 
6) DEPC-Treated Double Distilled Water (DEPC-Treated Water) 
It was the same as stated in the section 2.1.3.1.1.1. 
7) Electrophoresis Apparatus 
They were purchased from Bio-Rad Laboratories (Hercules, CA, 
USA). 
8) 0.24-9.5 Kb RNA Ladder 
It was purchased from Invitrogen, Life Technology (Carlsbad, CA, 
USA) 
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2.1.3.1.1.4 Reagents for the Transfer of RNA to Membrane BrightStar� Plus 
Positively Charged Nylon Membrane 
The membrane was purchased from Ambion Inc. (Austin, TX, USA) 
1) Sodium Chloride-Sodium Citrate Buffer (SSC) (20X) 
It was prepared by dissolving 77 g of citric acid, trisodium salt (Sigma， 
St. Louis, MO, USA) and 175 g of sodium chloride in double distilled 
water to make up to 1 liter and stirred at room temperature. 
2) Sodium Chloride-Sodium Citrate Buffer (SSC) (2X) 
It was prepared by diluting 20X SSSC for 10 folds with double 
distilled water. 
3) Whatman 3MM Chromatography Papers 
It was purchased from Whatman (Kent, UK). 
4) HL-2000 Hybrilanker Hybridizer System 230V 
It composed of a hybridizer and an UV crosslinker (254nm UV) 
purchased from UVP (Inc. Upland, CA, USA) 
2.1.3.1.1.5 Reagents for Probe Synthesis and Labelling 




It was synthesized by Invitrogen, Life Technologies (Carlsbad, CA, 
USA). The lyophilized primers were reconstituted in autoclaved 
double distilled water to a concentration of 100 juM and stored 
at —20�C. 
2) Reverse Transcriptase 
RevertAidTM H Minus M-MuLV Reverse Transcriptase together with 
a 5X reaction buffer were purchased from Fermentas (Hanover, MD, 
USA). The enzyme was supplied at a concentration of 200 U/)Ltl stored 
at - 20 °C in a buffer containing 50 mM Tris-HCl (pH 8.3), 0.1 M 
NaCl, 1 mM EDTA, 5 mM DTT，0.1% (v/v) Triton X-100, and 50% 
(v/v) glycerol. The 5X reaction buffer contained 250 mM Tris-HCl 
(pH 8.3), 250 mM KCl，20 mM MgCl and 50 mM DTT. 
3) Ribonuclease Inhibitor 
RNAGuard ribonuclease inhibitor isolated from human placenta was 
purchased from Amersham Biosciences (Buckinghamshire, UK). It 
was supplied at 30 U/fil and stored at —20�C in a buffer that contains 
20 mM HEPES-KOH, pH 7.6，50 mM KCl, 5 mM DTT, and 50% (v/v) 
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glycerol. 
B) Reagents for Polymerase Chain Reaction (PCR) 
1) DNA Taq Polymerase and Deoxyribonucleoside Triphosphate 
(dNTP) Mix 
Taq polymerase (Thermus aquaticus) supplied at 5 U/|LI1 together with 
lOX reaction buffer and 20 mM dNTP mix were purchased from 
Amersham Biosciences (Buckinghamshire, UK). The lOX reaction 
buffer contained 100 mM Tris-HCl，pH 9.0, 15 mM MgCh solution, 
and 500 mM KCl. They were stored at -20°C. 
2) Primer Pairs 
The oligonucleotide primers used in PCR were designed on the basis 
of the published sequences of genes on NCBI and synthesized by 
Invitrogen, Life Technologies (Carlsbad, CA, USA). The lyophilized 
primer pairs were reconstituted in autoclaved double distilled water to 
stock concentration of 100 |LIM. A working solution of 10 ]LIM was 
diluted from the stock solution by adding 10 \il of stock solution to 90 
\xl of autoclaved double distilled water. Both the stock and working 
solution were kept at -20°C. 
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Table 2.1: Primer sequences for PCR reaction 
Gene Product Tm 
Sequences 
(bp) (oQ 
Beta-Actin F 5' "aiAQM3[Ma\am]M"C—3’ _ 
830 55 
Beta-Actin R 5' -CTa\QB\Qj^Q[MTa\TCT-3' 
ApoEF 5' " ( I A ( H I M A a m i M a > 3 ’ … ^^ 
613 60 
ApoER 5' -aJTQ0GCACrTaJQC7\Q>3' 
BDNFF 5' -ATa\amXJTTTaJTACrATaJ-3’ _ 
747 55 
BDNFR 5' -T(JTQ0GCJTTTMTaJCWGrAC-3' 
NGFF 5' -TAOUMTGrCIATGrTGr-S' _ 
433 55 
NGFR 5，-TQ\a\GrGra\GrATGrQ3>3 
N T - 3 F 5 ' ~a^GrTT(i i^Qve\crcrcr-3， 
— 477 55 
NT-3R 5' ~anjTTTa\Tcrcra iMCA-3, 
NT-4/5 F 5' - < C T Q T C T c r ( r r a x n T a j T - 3 ' 产 _ 
765 55 
NT-4/5 R 5' ~ a x x A a \ c r Q ^ a j c r a v v \ - 3 
HMG-CoA reductase F 5' -丁 
792 55 
HMG-CoA reductase R 5’ -/W\a\ai>\aW\a:MQ7\—3 
siooB F 5' - M G r a x A ( n 7 \ G r a j c r c r - 3 ’ 
400 60 
SIOOB R 5’ -CTa\CrCATGrTaW\QV\CTC-3' 
FASNF ； 520 55 
FASNR 5' -aV\TGra\Q3QgrTQ:jaJ1'-3 
HMGCSl F 5' -TTTaJATa\CrQuMTG33>3' 
739 55 
HMGCSl R 5’ ~GTQV\TAQCra\aXJAQ>3, 
HMGCS2 F 5' -<J(mJ000JWV\aG\TA-3' 
； 904 55 
HMGCS2 R 5' -CrTG^TQV\CATG^CIAQ^^^-3 
3) Gel Extraction Kit 
DNA fragments from agarose gel were purified by MinElute Gel 
Extraction Kit purchased from Qiagen (Valencia, CA，USA). 
4) BrightStar® Psoralen-Biotin Nonisotopic Labeling Kit 
The kit was purchased from Ambion Inc. (Austin, TX, USA) stored 
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at -20^C. 
5) DNA Ladder Marker 
The 100 bp and 1 kbp DNA markers were purchased from Fermentus 
(Hanover, MD, USA). The working solution was prepared by mixing 
1 volume of stock DNA markers and 1 volume of 6X loading dye with 
4 volumes of autoclaved double distilled water. The stock solution 
was kept at -20°C while the working solution was stored at 4°C. For 
each agarose gel, 1.5 fal of working solution was loaded. 
2.1.3.1.1.6 Reagents for Hybridization 
1) ULTRAhyb® hybridization buffer 
It was purchased from Ambion Inc. (Austin, TX, USA) stored at 4°C. 
2) SDS Solution (20%) 
It was prepared by dissolving 200 g SDS (USB, Swampscott, MA, 
USA) in 1 L double distilled water and stored at room temperature. 
3) Low Stringency Washing Buffer (2X SSC, 1% SDS) 
It was prepared by adding 100 ml 20X SSC and 50 ml 20% SDS 
solution in 1 L double distilled water. 
4) High Stringency Washing Buffer (O.IX SSC, 0.1% SDS) 
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It was prepared by adding 5 ml of 20X SSC and 5 ml of 20% SDS 
solution in 1 L of double distilled water. 
2.1.3.1.1.7 Reagents for Streptavidin/ Alkaline Phosphatase/ CDP-Star 
Detection 
1) BrightStar® Biodetect Kit 
The kit was supplied with a blocking buffer, a 5X wash buffer, 
CDP-Star®, Streptavidin-Alkaline Phosphatase, and lOX assay buffer 
purchased from Ambion Inc. (Austin, TX，USA) stored at 4°C. 
2) X-ray film 
The X-ray film was purchased from Roche Applied Science 
(Indianapolis, IN, USA) and stored in darkness at room temperature. 
2.1.3.2 Reagents and Buffers for Western Blot Analysis 
2.1.3.2.1 Protein Assay 
1) Cell Lysis Buffer 
The cell lysis buffer contained 1% (w/v) SDS, 1 mM sodium 
orthovanadate (NasVCU), 10 mM Tris (pH 7.4), 21 )ig/ml aprotinin, 5 
|Lig/ml leupeptin, 1 mM phenylmethylsulfonyl fluoride (PMSF) and 5 
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mM magnesium chloride (MgQb) in double distilled water. Aliquots 
of 1 ml were kept at 4°C until use. 
2) Detergent Compatible (DC) Assay Kit 
Protein concentration was measured by DC protein assay kit 
purchased from Bio-Rad Laboratories (Hercules, CA, USA). 
3) Bovin Serum Albumin (BSA) 
BSA standards (Sigma, St. Louis, MO, USA) were prepared as 1 
mg/ml stock in autoclaved double distilled water and aliquots of 500 
|Lil was stored at —20°C. 
4) Spectrophotometric Cuvette 
The 1 ml plastic cuvette used for spectrophotometry was purchased 
from Sarstedt (Numbrecht, Germany). 
5) Spectrometer 
The concentrations of the protein samples were determined 
spectrophotometrically by BioPhotometer (Eppendorf, Hamburg, 
Germany). 
2.1.3.2.2 Reagents for SDS Polyacrylamide Electrophoresis of Proteins 
1) 30% (w/v) Acrylamide / Bis Solution, 37.5:1 
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The ready-to-use 500 ml acrylamide solution containing 30% (w/v) of 
aery lam ide (146.1 g) and N,N ‘ -methylene-bis-acrylamide (3.9 g) for a 
total monomer to crosslinker ratio of 37.5:1 was purchased from 
Bio-Rad Laboratories (Hercules, CA, USA). It was light-protected 
and stored at 4°C until use. 
2) Stacking Gel Buffer 
It was a 0.5 M Tris-HCl buffer containing 0.4% SDS adjusted to pH 
6.8 and kept at 4�C. 
3) Running Gel Buffer 
It was a 1.5 M Tris-HCl buffer containing 0.4% SDS adjusted to pH 
8.8 and kept at 4°C. 
4) 10% Ammonium Persulfate (APS) 
APS (10%, w/v) purchased from USB (Swampscott, MA, USA) was 
freshly prepared before use. 
5) N,N,N',N'-Tetra-methylethylenediamine (TEMED) 
TEMED purchased from Bio-Rad Laboratories (Hercules, CA, USA) 
was the last to add to initiate the polymerization of the 
SDS-polyacrylamide gel. It was stored at 4°C until use. 
6) SDS Gel Loading Buffer (4X) 
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SDS gel loading buffer (4X) containing p-mercaptoethanol (Bio-Rad 
Laboratories, Hercules, CA, USA) and bromophenol blue was 
prepared by mixing 0.8 ml of 0.05% (w/v) bromophenol blue, 1 ml of 
0.5 M Tris-HCl at pH 6.8, 1.6 ml of glycerol, 1.6 ml of 20% (w/v) 
SDS, 3.8 ml of double distilled water and 0.3 ml of 
3-mercaptoethanol. The buffer was stored at 4°C until use. 
7) Pre stained Protein Standard 
The prestained SDS-PAGE standards (broad range) were purchased 
from Bio-Rad Laboratories (Hercules, CA, USA). The standard 
colored proteins prepared in 33% (v/v) glycerol, 3% SDS, 10 mM Tris 
(pH 7), 10 mM DTT，2 mM EDTA and 0.01% NaNs were stored 
at -20°C until use. 
8) Tris-Glycine-SDS Electrophoresis Buffer (lOX) 
The lOX electrode buffer containing 0.25 M Tris-HCl at pH 8.3, 1.92 
M glycine and 1% SDS in double distilled water was stored at room 
temperature. The lOX buffer was freshly diluted to IX working buffer 
solution with double distilled water for SDS-PAGE. 
9) Coomassie Blue Staining and Destaining Solution 
The staining solution was prepared by dissolving 0.25 g of Coomassie 
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R-250 with 10 ml of acetic acid, 50 ml of methanol and 50 ml of 
double distilled water. The mixture was stirred for 2 hours and then 
stored at room temperature. For the destaining solution, it was 
prepared by mixing one volume of acetic acid, three volumes of 
methanol and ten volumes of double distilled water. 
2.1.3.2.3 Reagents for the Transfer of Protein to Membrane and Signal 
Detection 
1) Tris-Glycine Buffer (lOX) 
Tris-glycine lOX concentrate buffer containing 0.25 M Tris base and 
1.9 M glycine in double distilled water was stored at room 
temperature. 
2) Tris-Glycine-methanoi Transfer Buffer (IX) 
The transfer buffer was prepared by mixing 100 ml of methanol with 
100 ml of lOX concentrate of Tris-glycine buffer and 800 ml of 
double distilled water. The buffer solution was freshly prepared before 
use. 
3) Hybond ECL nitrocellulose membrane 
The nitrocellulose Hybond ECL membrane was purchased from 
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Amersham Biosciences (Buckinghamshire, UK) and kept at room 
temperature. 
4) Electrophoresis and Transfer Apparatus 
They were purchased from Bio-Rad Laboratories (Hercules, CA, 
USA). 
5) Tris-buffered Saline (TBS) 
TBS of lOX concentrate containing 0.2 M Tris base, 1.37 M NaCl, 
and 38 ml 1 M HCl was adjusted to pH 7.6 and stored at room 
temperature. 
6) TBS-Tween (Washing Buffer) 
The washing buffer was prepared by adding 0.1% (v/v) of Tween 20 
(USB, Swampscott, MA, USA) in 100 ml of lOX TBS and 900 ml of 
double distilled water. The solution was freshly prepared before use. 
7) 5% Nonfat Milk Solution (Blocking Buffer) 
It was prepared by dissolving nonfat milk powder in washing buffer at 
a concentration of 5% (w/v). 
8) Primary Antibodies 
Rabbit polyclonal anti-BDNF antibody supplied at 0.5mg was 
purchased from Chemicon International, Inc. (Temecula, CA, USA). 
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The antibody was reconstituted to Img/ml and stored as 50 jiil aliquots 
at -20°C. 
Rabbit polyclonal anti-NGF antibody supplied at 0.5mg was 
purchased from Chemicon International, Inc. (Temecula, CA, USA). 
The antibody was reconstituted to Img/ml stored as small aliquots at 
-20�C. 
Rabbit polyclonal anti-NT-3 antibody supplied at 0.5mg was 
purchased from Chemicon International, Inc. (Temecula, CA, USA). 
The antibody was reconstituted to Img/ml stored as 50 \il aliquots at 
-20。C. 
Mouse monoclonal anti-beta actin antibody was purchased from 
Sigma (St. Louis, MO, USA) and stored at —20�C. 
9) Secondary Antibodies 
Anti-rabbit and anti-mouse IgG, peroxidase-linked species-specific 
antibody was purchased from Cell Signaling Technology (Beverly, 
MA, USA) and Zymed Laboratories, Inc. (San Francisco, CA, USA) 
respectively. 
10) ECL™ Western Blotting Detection Reagents 
The Western blotting detection reagents (Amersham Biosciences, 
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Buckinghamshire, UK) were stored at 4�C. 
11) X-ray Film 
The X-ray film was purchased from Roche Applied Science 
(Indianapolis, IN, USA) and stored in darkness at room temperature. 
2.1.4 Study of Lipid in Glial cells 
2.1.4.1 Determination of Gene Expressions in Lipid Metabolism 
1) Reagents and Buffers for Northern Blot Analysis 
Reagents are the same as stated in 2.1.3.1.1. 
2) Reagents and Buffers for RT-PCR 
Reagents are the same as stated in 2.1.3.1.1.5. 
2.1.4.2 Reagents for Determination of Cholesterol and Fatty Acid Levels by 
Gas Chromatography 
1) Glyceryl Triheptadecanoate 
Glyceryl triheptadecanoate was purchased from Sigma (St. Louis, MO, 
USA) and prepared as stock of 1 mg/ml stored at 4°C 
2) Stigmastanol 
Stigmastanol was purchased from Sigma (St. Louis, MO, USA) and 
prepared as stock of Img/ml stored at room temperature. 
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3) Sigma-Sil-A Reagent 
It was a trimethylchlorosilane: hexamethyldisilazane: pyridine (1:3:9) 
reagent for preparing TMS derivatives of fatty acids purchased from 
Sigma (St. Louis, MO, USA). 
4) Boron trifluoride-methanol (BF3) solution 
BF3 supplied as 14% w/v in methanol was purchased from Sigma (St. 
Louis, MO, USA) and was stored at 4°C. 
5) Organic Solvents 
Chloroform ACS HPLC grade and hexane in HPLC grade were 
purchased from Sigma (St. Louis, MO, USA) and stored at room 
temperature. 
Cyclohexane in HPLC grade and toluene was purchased from 
Advanced Technology and Industrial Co. Ltd. (Hong Kong, China). 
6) 1 mol/L NaOH in 90% Ethanol (w/v) 
Each liter of the solution was prepared by dissolving 40g of NaOH 
(ICN BioMedicals Inc.，Irvine，CA，USA) in 100 ml of double 
distilled water and added to 900ml absolute ethanol. Solution was 
stored in darkness at room temperature. 
7) PYREX® brand Culture T\ibes with Screw Cap 
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They were purchased from Corning (NY, USA) 
8) Dimethylchlorosilane (DMCS) Solution 
The solution was prepared by dissolving 10% (w/v) DMCS in toluene 
AR grade. 
9) Shimadzu GC-14B Gas-liquid chromatography system 
Analysis of the cholesterol TMS-ether derivative was performed in a 
fused silica capillary column (SAC-5, 30 m x 0.25 mm, i.d.; Supelco， 
Beliefonte，PA) using a Shimadzu GC-14 B gas-liquid chromatograph 
equipped with a flame ionization detector (Kyoto, Japan). 
10) Gas Chromatography and Mass Selective Detector (GC-MSD) 
Fatty acid methyl ester (FAME) analysis was preformed with column 
HP19019S-433 HP-5MS (30 m in length with 0.25 mm internal 
diameter) in Hewlett-Packard 6890N gas chromatography system 
interfaced to a Agilent - HP 5973 N Mass Selective Detector 
manufactured by Agilent Technologies (Palo Alto, CA，USA). 
11) Bovin Serum Albumin (BSA) 
BSA standards (Sigma, St. Louis, MO, USA) were prepared as 1 
mg/ml stock in autoclaved double distilled water and aliquots of 500 
\xl was stored at —20°C. 
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12) Bradford reagent 
Protein concentration was measured by Bradford reagent purchased 
from Bio-Rad Laboratories (Hercules, CA, USA). 
13) Spectrophotometric Cuvette 
The 1 ml plastic cuvette used for spectrophotometry was purchased 
from Sarstedt (Numbrecht, Germany). 
14) Spectrometer 
The concentrations of the protein samples were determined 




2.2.1 Cell culture 
2.2.1.1 Maintenance of C6 cells 
C6 cells were maintained in complete medium at 37°C with 5%/95% 
C02/air (v/v). Cells were passed once for every 72 hours at a ratio of 1 
to 50. 
2.2.1.2 Primary Culture of Rat Astrocytes 
2-day old SD rat (Animal House, CUHK, HKSAR, China) were used in 
the present experiments. Ethics approval was obtained from Animal 
Research Ethic Committee, the guidelines of the Laboratory Animal 
Services Center were followed. Astrocytes in primary culture were 
obtained from cerebral cortex of SD rat. Areas of dissection were 
cleaned with 70% ethanoL Rats were decapitated with a pair of sterile 
operating scissors that were regularly rinsed with 70% ethanoL Dissection 
was started from cutting the midline of the head, from the base to the 
mid-eye area. Brains were removed from the opened skulls. Olfactory 
lobes and meninges were removed. The hemisphere were collected in 
sterile PBS and cut into small pieces of � 1 m m diameter with scissors. 
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Tissues in 5ml PBS were incubated with 5ml 0.25% trypsin (Gibco, 
Carlsbad, California, USA) in 15ml centrifugate tube in 3 7 � C water bath 
for 15 minutes and inverting the tube every 3 minutes. Cells were 
centrifuged at 1800 rpm for 5 minutes. After removing the excessive 
solution, trypsinized cells were resuspened in high glucose DMEM 
(Gibco, Carlsbad, California, USA) with 50% FBS (Gibco, Carlsbad， 
California，USA) and triturated through needles with 3mm internal 
diameter syringes. Finally, dispersed cells were subjected to pass through 
70micro nylon mesh filter (Rancho Dominguez，CA, USA) in a filter 
holder (Millipore，Billerica, MA, USA) by a syringe and seeded in tissue 
culture flasks. Cells were incubated in a humidified incubator of 5%/95% 
CCVair at 37°C in complete medium which was changed for every 72 
hours. Until day 8, cells were shaken for 8 hours at 220 rpm, 37°C for 
selection. Detached cells were removed immediately. Remaining 
astrocytes were removed from flask with 0.05% trypsin (Gibco, Carlsbad, 
California, USA) and seeded into new tissue culture flasks or plates for 
experiment. 
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2.2.2 Study of Growth Properties of Glial Cells 
2.2.2.1 Construction of cell growth curve 
C6 cells (5,000 cells/well) and astrocytes (10,000 cells/well) were plated 
in 24-well plates for 24 hours in complete medium and followed with 
serum starvation in high glucose DMEM with 0.1% of FBS for 48 hours. 
Quiescent cells were then switch to assay media with 1，2, and 3 mM of 
glucose. Cell numbers were determined periodically. Media with 
different glucose concentration supplemented with 1% FBS were changed 
every for 72 hours throughout the course of experiments. At the indicated 
time points, cells were trypsinized and detached from the plates, and cell 
number was counted using a hemacytometer. Each experiment was 
performed in quantaplicate and repeated 3 times. 
2.2.2.2 Flow Cytometric Analysis of Cell Cycle Profile 
C6 cells (195,000 cell/dish) were plated in 100 mm dish for 24 hours and 
synchronized by incubating in media supplemented with 0.1% FBS for 48 
hours in 37°C incubator. After that, the culture media was replaced with 
media containing 10% FBS for 24 hours. At the time of harvesting, cells 
were trypsinized, washed with PBS and pelleted by centrifugation at 
2,000 rpm for 5 minutes at room temperature. Cells were then fixed with 
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ice-cold 70% ethanol (Iml/well) at -20°C overnight. For staining, fixed 
cells were centrifuged at 2,000 rpm for 10 minutes at 4°C. After removing 
the ethanol, cells were resuspended in 600 jul DNA staining solution 
containing 8 ]ig/ml RNase A and 40 \ig/m\ propidium iodide (PI) and 
incubated for 15 minutes at 37�C. Stained cells were analyzed for 
fluorescence intensity with a fluorescence-activated cell sorter (Becton 
Dickinson FACSort) equipped with an argon laser with emitting 
wavelength 488 nm，using the CellQuest software. A minimum of 10,000 
events were acquired for each determination. The percentages of cells in 
Go/Gi, S and G2/M cell cycle phases were calculated by CellQuest 
software. 
2.2.2.3 Measurement of DNA Synthesis 
C6 cells (5,000 cell/well) and astrocytes (50,000 cell/well) were plated in 
24-well plates for 24 hours in complete medium and synchronized by 
incubating in medium containing 0.1% FBS for 48 hours. After 
synchronization, cells were washed twice with IX PBS and incubated in 
assay media with 1, 2, and 3 mM glucose supplement with l|uCi/ml of 
^H-thymidine for 24 hours respectively. At the end of incubation, media 
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were removed and cells were washed twice with 500|j.l/well of ice-cold 
PBS. Cells were then fixed with 500|Lil/well of ice-cold 10% TCA for 1 
hour on ice. Cells were further washed twice with 500|Lil/well of ice-cold 
10% TCA to remove unincorporated tritiated thymidine. Cells were then 
lysed with 400]Lil/well of IN NaOH and incubate at 37�C for two hours. 
All solution was subjected to radioactive counting by adding 4ml of 
scintillation fluid. Each experiment was repeated 3 times with each 
condition performed in 4 replicates. 
2.2.3 Study of Neurotrophic Properties 
2.2.3.1 Determination of Neurotrophic Factor Productions 
2.2.3.1.1 Northern Blot Analysis 
2.2.3.1.1.1 RNA Extraction 
C6 cells (195,000 cell/dish) were plated in 100 mm culture dishes for 
24 hours in complete medium while primary astrocytes (1,000,000 
cell/dish) were seeded in 100 mm culture dishes and incubate in 
complete medium until confluence (6 days) with medium change on 
day 3 before media switch. Cells were washed twice with IX PBS 
and incubated in assay media with 1，2, and 3 mM glucose for further 
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120 hours (5 days) with the change of medium at the 72-hours (day 3) 
respectively. At the end of incubation, media were removed and cells 
were homogenized by 1.5 ml of TRI reagent at room temperature for 
5 minutes to allow complete dissociation of nucleoprotein complexes. 
Cell lysates were then scraped down and transferred to a 1.5 ml 
microcentrifuge tube. RNA was extracted by supplementing the 
homogenate with BCP (0.1 ml / ml TRI reagent) followed by vigorous 
shaking for 15 seconds. After incubation at room temperature for 10 
minutes, the mixture was centrifuged at 12,000 x g for 15 minutes at 
4°C for phase separation. Following centrifugation，RNA was 
exclusively found in the colorless upper aqueous phase whereas DNA 
and proteins were remained in the interphase and organic phase 
respectively. The upper aqueous layer ( � 0 . 6 ml / ml of TRI reagent) 
was collected and transferred to a new 1.5 ml microcentrifuge tube. 
RNA was then precipitated from the aqueous phase by mixing with 
isopropyl alcohol (0.5 ml / ml of TRI reagent) and stored at -20°C 
overnight. On the following day, RNA was pelleted by centrifugation 
at 12,000 X g for 15 minutes at 4°C. After removing the supernatants 
by aspiration, the RNA pellets were washed with 75% ethanol (1 ml / 
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ml TRI reagent) and centrifuged at 12,000 x g for 5 minutes at 4°C. 
Ethanol was removed and the RNA pellets were air-dried for 20 
minutes at room temperature. The RNA pellets were finally 
resuspended in 30-50 jul DEPC-treated water. RNA concentration was 
quantified spectrophotometrically by BioPhotometer (Eppendorf, 
Hamburg, Germany) at 260 nm. The purity was estimated by the ratio 
of A260/A280 and only samples with values higher than 1.7 were used 
for further experiment. The integrity of the isolated RNA was checked 
by gel electrophoresis on 1% agarose gel and two predominant bands 
of 18S (~2 kb) and 28S ( � 5 kb) ribosomal RNA, low molecular 
weight (0.1-0.3 kb) RNA, and discrete bands of high molecular 
weight (7-15 kb) RNA were visualized. 
2.2.3.1.1.2 Denaturing Gel Electrophoresis 
All the procedures were followed according to the instruction manual 
of the NorthernMax Kit purchased from Ambion, Inc. (Austin, TX, 
USA). Every apparatus used were first incubated with 1% of SDS, 
then rinsed with 70% ethanol and DEPC-treated water to remoce the 
RNase. 100ml of gel was prepared from 1 or 1.5% (w/v) agarose 
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heated in 72ml DEPC-treated water with microwave of 600 W for 2 
minutes. The hot agarose solution was allowed to cool down to 
about 60�C and added with 10 ml of lOX MOPS running buffer and 
18 ml of 12.3M formaldehyde (37% w/v). The mixture was poured 
into an electrophoresis apparatus with comb and allowed to set for 1 
hour at room temperature in a chemical hood. 25 j^ g of total RNA 
was mixed with 3X formamide-loading buffer with 1 jug/ml EtBr for 
the direct visualization of RNA after electrophoresis. RNA samples 
as well as the RNA ladder were subjected for denaturation at 6 5 � � f o r 
5 minutes and were fractionated on a denaturing agarose gel in IX 
MOPS running buffer at 40-60V for 5 hours. The gel was 
photographed under UV light before proceeding to the next step. 
2.2.3.1.1.3 Transfer of RNA to Membrane 
RNA was transferred from the agarose gel onto BrightStar®Plus 
Positively Charged Nylon membrane with the downward capillary 
transfer method with the 20X SSC as transfer buffer. A nylon 
membrane, 8 pieces of 3 MM chromatography paper and 5 inches 
paper towels together with salt bridge, a buffer tray, a support, and a 
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cover with weight 150 g were used for transfer assembly (Figure 2.1). 
The whole set-up was covered by a wrapping film to avoid 
evaporation. After the 18-hour of transfer, the membrane was 
detached from the gel after marking the position of wells. 
Membrane was then rinsed in 2X SSC to remove excessive salt and 
agarose. The membrane was subjected to UV cross-linking. 
Transfer efficiency was verified by examining the agarose gel under 
UV light. Membrane was used immediately or stored at 4°C. 
Cover • ^ • 
Bridge ^ 
(Ghrom^ tagr'aphy Paper) — 
Chromota^ raphiy Paper ^^^^^^^^^^^^^^^^^^^^^^^^^^ 
Membra 个 Transfer Buffer 
Chromotagraphy Pap绝r ^^ 
T t 丄 Support 
Figure 2.1 Assembly of transfer assembly (Ambion Inc. Austin, TX, USA). 
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2.2.3.1.1.4 Probe synthesis and labeling 
A) Reverse-Transcription 
Total RNA extracts were used as templates for producing cDNA using 
RevertAidTM H Minus M-MuLV Reverse Transcriptase. RT reactions 
were performed using 5 [ig of total cellular RNA per 20 jiil reaction 
mixture following the manufacturer's protocols. Template RNA was 
first mixed with 1 jitl of lOOmM oligo(dT)i5 and incubated at 70�C for 
5 minutes to denature the RNA. Then，4 ]i\ of 5X reaction buffer, 1 
|Lil of 20mM dNTP mix, 0.5 jiil (15 units) RNAGuard ribonuclease 
inhibitor and appropriate amount of DEPC-treated water were added 
to the mixture to make up a final volume of 19.8 JJI After a further 
incubation at 37°C for 5 minutes, 0.2 \il of M-MuLV reverse 
transcriptase (200U/ul) was finally added. The 20 jul reaction mixture 
was incubated at 42°C for 90 minutes for cDNA synthesis, followed 
by 70�C for 10 minutes for inactivating the reverse transcriptase and 
then cooled to 4�C. The resulting cDNA samples were then diluted 
with 180 jLil DEPC-treated water and stored at -20°C until further use. 
B) Polymerase Chain Reaction (PGR) 
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PCR were performed in 25 jul reaction mixture containing 5 jiil diluted 
cDNA equivalent to 0.125 jug of total RNA, 2.5 jul lOX reaction buffer, 
0.25 ]il of 20 mM dNTP mix, 1 units of Taq DNA Polymerase 
(Amersham), 0.5 |LI1 of 10 mM of both forward and reverse 
oligonucleotide primers by the Mastercycler gradient (Eppendorf, 
Hamburg, Germany). Cycling conditions comprised an initial 
denaturation of 5 minutes at 95�C，followed by 40 to 44 cycles with 
denaturation at 95°C for 45 seconds, annealing at 5 5 � C and elongation 
at 72°C for 60 seconds. The PCR conditions were optimized by 
varying the annealing temperature and the number of cycles so as to 
produce sufficient amount of products for probe synthesis. 
C) PCR products purification and labeling 
PCR products were loaded in 1% (w/v) agarose gel together with the 
100 bp DNA marker. The DNA fragments were identified according 
to the mobility. DNA fragments from agarose gel were purified by 
MinElute Gel Extraction Kit purchased from Qiagen (Valencia, CA, 
USA). All the procedures were followed according to the instruction 
manual. Purified PCR products specific to the target genes were 
64 . 
eluted from the column with IX TE buffer provided by the 
BrightStar® Psoralen-Biotin nonisotopic labeling kit. 10 |LI1 (50 ng) 
of DNA product in IX TE buffer were heated at 9 9 � C in thin-wall 
PCR tube by incubating in the Mastercycler gradient (Eppendorf, 
Hamburg, Germany) for 10 minutes. Samples were chilled on 
ice-water bath immediately after heating. The samples were ready 
for labeling. In dim light，Ifil of BrightStar Psoralen-Biotin was 
added into each tube and pipetted up-and-down for 5 times. Samples 
were transferred to ice-chilled 96-well plate and the plate was put 
under the UV light source (365 nm) directly and allows crosslinkage 
of nucleic acid for 45 minutes. 89 \xl IX TE buffer were added to 
samples and diluted probe was transferee! to new centrifuge tube. 
Remove non-crosslinked BrightStar Psoralen-Biotin was removed by 
extraction with 200 [i\ water-saturated n-Butanol twice. Probes were 
ready to use or stored as aliquots of 30 \xl with concentration of 5 ng 
/\il at -80�C. 
D) Hybridization 
Blots were hybridized with biotin-labeled DNA probes at a final 
concentration of 30ng/ml ULTRAhyb® at 42�C for 14 hours. Then, 
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membranes were washed twice with low stringency wash solution for 
5 minutes at room temperature followed by high stringency wash 
twice at 42°C for 15 minutes. 
E) Streptavidin/Alkaline Phosphatase/CDP-Star Detection 
BrightStar® Biodetect Kit was used for detection. Membranes were 
washed twice with IX wash buffer and blocking buffer followed with 
30 minutes of the blocking of the membranes with blocking buffer. 
Phosphatase-conjugated streptavidin was diluted in the blocking 
buffer and labeled the target probe in the next 30 minutes. 
Membranes were blocked with blocking buffer for 15 minutes, wash 
three times with IX wash buffer for 10 minutes each and then washed 
twice with assay buffer for 2 minutes each. Chemiluminescent 
detection was carried out by adding CDP-star substrate and exposure 
to X-ray films for 4 to 24 hours. 
F) Quantification of northern blot signals 
The bands on the films were scanned and saved as inverted grayscale 
JPEC formats. Relative intensity of target bands was then measured 
by the Image J software (NIMH, NIH, Bethesda，Maryland, USA). 
66 . 
All raw intensities were background-corrected to reduce the effects of 
non-specific signals and normalized with B-actin gene. The results 
of the experimental groups were expressed as fraction of the control 
group for comparison. 
2.2.3.1.2 Western Blot Analysis 
2.2.3.1.2.1 Protein Extraction 
C6 cells (195,000 cell/dish) were plated in 100 mm culture dishes for 
24 hours in complete medium while primary astrocytes (1,000,000 
cell/dish) were seed in 100 mm culture dishes and incubated in 
complete medium until confluence (6 days) with media change on day 
3 before media switch. Cells were washed twice with IX PBS and 
incubated in assay media with 1, 2, and 3 mM glucose for further 120 
hours (5 days) with the change of medium at the 72-hours (day 3). At 
the end of incubation, media were removed and cells were washed 
twice with IX PBS and detached from dish by trypsin. Cells were 
transferee! to centrifuge tube followed by centrifugation at 700 x g for 
5 minutes at room temperature. Cell pellets were washed with PBS for 
2 more times and collected by centrifugation. Cell pellets were then 
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resuspended and vortexed vigorously with lysis buffer and incubated 
on ice at -20°C for 3 hours. The cell lysates were boiled at 100�C for 
10 minutes and then centrifugated at 13,000 x g for 7 minutes at 4 � C . 
The resulting supernatants were transferred to new microcentrifuge 
tubes and stored at -20°C for further assay. 
2.2.3.1.2.2 Quantification of Proteins 
The protein contents of the cell lysate and concentrated media were 
estimated by the detergent-compatible protein assay system from 
Bio-Rad Laboratories (Hercules, CA, USA) with BSA as the standard. 
BSA solutions at 0.2 mg/ml，0.4mg/ml, 0.6mg/ml, 0.8mg/ml and 
Img/ml were prepared by dissolving in lysis buffer from 1 mg/ml 
BSA stock solution by serial dilution. Three microliters protein 
samples were diluted with 27 ]LI1 lysis buffer. Diluted BSA standards 
or protein samples (12.5 were mixed with 62.5 |LI1 of reagent A，， 
followed by an addition of 500 )LI1 reagent B in a 1-ml plastic cuvette. 
The reaction mixtures were allowed to stand in darkness at room 
temperature for 15 minutes before absorbance at 750 nm was recorded 
using the dye reagent as the blank. Both standards and samples were 
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measured in duplicate. The concentrations of the protein samples were 
determined spectrophotometrically. Equal amount (150 jig) of 
protein samples were subjected to SDS-PAGE analysis. 
2.2.3.1.2.3 Detection of Protein by Western Blot Analysis 
SDS-PAGE was carried out to separate the proteins according to 
molecular weights before Western blot. Table 2.2 shows the 
composition of the chemical reagents needed for casting 16% 
SDS-polyacrylamide gel. Samples containing the same amount of 
protein (150 |Lig) were mixed with 6X SDS gel loading buffer and 
boiled for 5 minutes before loading onto the SDS-polyacrylamide gel 
with a 5% stacking gel. Five microliters of prestained standards were 
loaded as molecular weight marker and the gel was run under constant 
voltage of 90 volts for 3 hours. 
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Table 2.2 Composition of the SDS-Polyacrylamide Gel 
^ 5% Stacking Gel 16% Running Gel 
Reagent 
— (5 ml) (5 ml) 
30% Acrylamide Stock 0.825 ml 5.33 ml 
Stacking Gel Buffer 1.25 ml -
Running Gel Buffer - 2.5 ml 
Distilled Water 2.875 ml 2.1ml 
10% APS 100 jul 
TEMED 3.3 6.6 |LI1 
After electrophoresis, the stacking gel was removed. The gel was 
rinsed briefly with distilled water to remove SDS that could hinder 
protein transfer. Thereafter, the gel was equilibrated in transfer buffer 
for 5 minutes. One piece of Hybond ECL membrane, two pieces of 3 
MM Whatmann chromatography papers and two pieces of sponge 
were pre-wetted with transfer buffer. They were assembled in the wet 
blotting apparatus from Bio-Rad Laboratories (Hercules, CA, USA). 
Air bubbles were excluded by rolling a plastic tube on the membrane. 
The proteins on the gel were then electroblotted onto the Hybond ECL 
membrane at 110 volts for 2 hours. The whole apparatus was placed 
inside an ice bath to facilitate heat dissipation. After the transfer, the 
membrane with transferred proteins was washed for 10 minutes with 
two changes of TBS-T washing buffer. For detection of NGF and 
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NT-3, the membrane was incubated with washing buffer containing 
5% nonfat dried milk with constant shaking for 1 hour at room 
temperature to block the non-specific sites for probing. The membrane 
was then incubated with the desired primary antibodies with 
appropriate concentrations (8 |Lig/ml rabbit anti-BDNF; 1 jug/ml rabbit 
anti-NGF; 1 |Lig/ml of rabbit anti-NT-3) in TBS-T with 1% skim milk 
at 4 � C for 14 hours. After blotting with primary antibody, the 
membrane was briefly rinsed with washing buffer twice and then 
washed for three times for 5 minutes each followed with a final wash 
for 10 minutes. After washing, the membrane was incubated with 
horseradish peroxidase-linked secondary antibody in blocking buffer 
(1:2,000) for 2 hour at room temperature. Incubation was followed by 
three washes in washing buffer for 5 minutes each and a final round 
washing for 10 minutes. Then the membrane was subjected to ECL 
assay. 
2.2.3.1.2.4 Enhanced Chemiluminescent (ECI/M) Assay 
Equal volumes of ECL/M detection reagent 1 was freshly mixed with 
detection reagent 2 and pipetted onto the membrane. For each cm of 
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membrane, 10 fxl of detection reagent was required. The membrane 
was wrapped with cling wrap so that the surface of the membrane was 
covered with the detection reagent evenly and was allowed to react for 
1 minute. Excessive reagent is removed by holding the membrane 
vertically and touching the edge of the membrane against a tissue 
paper. The membrane covered with cling wrap, with the protein side 
down, was placed in the film cassette in which a sheet of X-ray film 
was placed inside in advance. The film was allowed to expose in 
darkness for 1 minute, 15 minutes and 2 hours. Finally, the film was 
developed and the immunoreactive bands could be visualized on the 
X-ray film. 
2.2.3.2 Determination of Gene Expression in Lipid Metabolism 
2.2.3.2.1 Northern Blot Analysis 
As stated in 2.2.3.1.1. 
2.2.3.2.2 RT-PCR 
As stated in 2.2.3.1.1.4A and 2.2.3.1.1.4B and except the cycle 
number were adjusted for each gene. 
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2.2.3.3 Study of Lipid Profiles in Glial Cells 
2.2.3.3.1 Sample preparation 
C6 cells (195,000 cell/dish) were plated in 100 mm culture dishes for 
24 hours in complete medium while primary astrocytes (1,000,000 
cell/dish) were seeded in 100 mm culture dishes and incubated in 
complete medium until confluence (6 days) with medium change on 
day 3 before media switch. Cells were washed twice with IX PBS 
and incubated in assay media with 1，2, and 3 mM glucose for further 
120 hours (5 days) with the change of medium at the 72-hours (day 3) 
respectively. Cells were then incubated in 30 ml assay media with 
1% FBS or 0% FBS with 1, 2 and 3 mM glucose concentrations for an 
additional 24 hours followed by lipid extraction. At the time of 
harvest, media were collected and cells were scraped off in 3 ml IX 
PBS for the analysis of total cholesterol and fatty acids. 
2.2.3.3.2 Total Cholesterol Determination 
Total lipids were extracted from media and cells using 15 ml and 3 ml 
chloroform/methanol (2:1, v/v) respectively with the addition of 150 
|Lig stigmastanol as an internal standard and the extraction steps were 
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repeated. After each extraction step, the bottom organic layer obtained 
after centrifugation was transferred to methylated tubes and dried 
down by nitrogen gas. The lipid extracts were then saponified with 1 
mol/L NaOH in 90% ethanol at 9 0 � C for 1 h. The tubes were then 
cooled down to room temperature with the addition of water and 
cyclohexane (1:5, v/v). After centrifugation, the upper organic layer 
containing the non-saponified substances including cholesterol was 
transferred to tubes specially treated with 10% dimethylchlorosilane 
in toluene and dried down by nitrogen gas. They were converted to 
their TMS-ether derivatives by TMS reagent at 60�C for 1 h. The 
TMS reagent was then dried by nitrogen gas and the pellets were 
dissolved in hexane. After vortex and centrifugation, the final hexane 
layer was collected for gas chromatography (GC) analysis. Analysis 
of cholesterol TMS-ether derivatives was performed in a fused silica 
capillary column (SAC-5, 30m X 0.25mm, i.d.; Supelco, Bellefonte, 
PA) using a Shimadzu GC-14 B gas-liquid chromatograph equipped 
with a flame ionization detector (Kyoto, Japan). 
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2.2.3.3.3 Total Fatty Acid Determination 
Total lipids were extracted from media and cells using 5 and 3 ml 
chloroform/methanol (2:1, v/v) respectively with the addition of 300 
|Lig heptadecanoic acid as an internal standard and the extraction steps 
were repeated. After each extraction step, the bottom organic layer 
obtained after centrifugation was transferred to methylation tubes and 
dried down by nitrogen gas. Methylation of fatty acids to their 
corresponding methyl esters was completed by the addition of 2 ml of 
14% (w/v) of BFs in methanol and 1 ml of toluene. Tubes were 
flushed with nitrogen gas for a while to remove oxygen，then capped 
tight immediately followed by heating at 9 0 � C for Ih. The tubes were 
cooled down to room temperature and mixed with hexane and water 
in 3:1 (v/v) ratio. After centrifugation, the upper organic layer with the 
fatty acid methyl ester (FAME) was collected in clean methylation 
tubes and dried down by nitrogen gas. The lipid samples were 
dissolved in hexane for GC analysis. Analysis of the FAME 
derivatives was performed with column HP19091S-433 HP-5MS in a 
Hewlett-Packard 6890N gas chromatography system interfaced to a 
Agilent - HP 5973 N Mass Selective Detector. The oven temperature 
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was programmed at initial temperature at 140�C，held at 4 minutes, 
ramp at 5 � C per minute to 300�C. The mass spectrometer device 
interface was set at 280�C. Helium was used as the carrier gas at a 
constant flow of 1 ml per minute in the whole process. The amount 
of total fatty acid was quantified according to the internal standard, 
heptadecanoic acid, added during the extraction step. 
2.2.3.3.4 Quantification of Proteins 
The protein contents of the cell lysate were estimated by the Bradford 
reagent with BSA as the standard. BSA solutions at 0.2 mg/ml, 
0.4mg/ml, 0.6mg/ml, 0.8mg/ml and Img/ml were prepared with lysis 
buffer from 1 mg/ml BSA stock solution by serial dilution. Diluted 
BSA standards or protein samples (20.0 jil) were placed in a 1-ml 
plastic cuvette, followed by the addition of 500 ]i\ diluted Bradford 
reagent. The reaction mixtures were allowed to stand at room 
temperature for 15 minutes before absorbance at 595 nm was recorded 
using the dye reagent as a blank. Both standards and samples were 
measured in duplicate. The concentrations of the protein samples were 
determined spectrophotometrically. 
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2.2.4 Statistical Analysis 
All experiments were performed at least twice and similar results 
were obtained in repeated experiment except Figure 3.7. The 
northern blot data of Figure 3.7 was re-confimed by semi-quantitative 
RT-PCR. Mann-Whitney Rank Sum Test was performed to detect 
statistic differences between 1 mM and 3 mM or 2 mM and 3 mM 
glucose with a significance determined at p<0.05 levels. Results 
from cells treated with 3 mM glucose concentration always serve as 
the control in the experiment. 
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Chapter 3 Results 
3.1 The Effects of Glucose Deficiency on Cell Proliferation 
In order to investigate the effects of glucose deficiency on cell growth，cells were 
allowed to grow in media with different glucose concentrations. Cells growing in 
media containing 3 mM glucose were considered as the control. Three different 
approaches were employed (1) direct cell count, (2) H-thymidine uptake assay and 
(3) flow cytometry. 
、 
3.1.1 Direct Cell Count Assay 
Since C6 cells and primary astrocytes were adherant when alive but floated when 
death，dead cells were removed upon media change and before trypsinization. 
Therefore, the numbers counted represented live cells. 
C6 cells responded differently to glucose deficiency at different growth phases. 
Figure 3.1 shows that the proliferation rate from the early to the mid log phase was 
the highest when cells were grown in 1 mM glucose concentraiton. The cell 
numbers were the highest when cells were growing in 1 mM glucose fiom day 1 to 
day 4, while they were the lowest in 3 mM glucose. The cell numbers in 2 mM 
glucose fell between those of 1 and 3 mM glucose. Interestingly, starting from mid 
log phase, the growth rate of C6 cells in 1 mM glucose slowed down as the growth of 
cells in 3 mM glucose continued. At the late log phase, cells in 1 mM glucose grew 
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at the lowest rate while cells in 3 mM grew at the highest rate. When the cells 
entered stationary phase, cell numbers in 3 mM glucose were significantly higher 
then that in 1 mM glucose (Figure 3.1). Cells growing in lower glucose 
concentrations gave lower population densities and shorter population doubling time 
(PDT) (Table 3.1). Values obtained from 2 mM glucose incubation usually fell 
between that of 1 mM and 3 mM. Thus, the effects of glucose on the growth of C6 
cells were dose- and growth phase-dependent. 
Although the data points did not show significant difference for primary 
astrocytes growing in different glucose concentrations (Figure 3.2), the growth 
patterns were consistent with those observed in C6 cells during the early log phase. 
During the log phase, primary astrocytes grew at a higher rate when incubating in 
media containing 1 mM as compared to those grew in 3 mM glucose. The growth 
data of 2 mM glucose fell between those obtained from 1 mM and 3 mM. 
Therefore, PDT was the shortest for cells growing in 1 mM glucose but the longest in 
3 mM glucose (Table 3.2). Since primary astrocytes decreased in cell number after 
day 4, the saturation density could not be determined. 
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Figure 3.1 Glucose deficiency stimulated C6 cell proliferation in the early log 
phase but restricted the saturation densities. C6 cells (5,000 cells/well) were 
seeded in 24-well plates in complete media. After 24 hours, cells underwent serum 
starvation with 0.1% FBS for 48 hours. On day 0, cells were washed with IX PBS 
twice and incubated in 1，2 and 3 mM glucose media. Cell numbers were counted 
at different time points as indicated. Data collected were used for plotting the 
growth curves and calculating the population-doubling-time (PDT) and saturation 
densities. PDT was calculated as the following, n = (log Y — log X) / log 2, where 
X is the initial cell number, Y is cell number at time T，n was the number of generation 
and T was the time in hours when cells were counted. PDT in hours was 
determined by dividing the T in hours by n. Table 3.1 shows the results of the 
calculation. Data were expressed as mean 土 SEM (n=4). Three independent 
experiments were performed with similar results obtained. ‘*'represents significant 
difference between 1 and 3 mM (p<0.05), ‘#, represents significant difference 
between 2 and 3 mM 
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[Glucose] 1 mM 2 mM 3 mM 
Population doubling time 
, \ 29.88 土 2.75 32.15 土0.24 37.11 土 1.54 
^ I I -
Saturation density 
, 2\ 1，418 土 231.6 * 2,388 土 492.6 # 3 ,371 土 715.8 
(cells / mm ) 
Table 3.1 PDT and saturation densities of C6 cells growing in different glucose 
concentrations. ‘*，represents significant difference between 1 and 3 mM (p<0.05). 
‘#’ represents significant difference between 2 and 3 mM (p<0.05). 
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Figure 3.2 Glucose deficiency stimulated primary astrocyte proliferation in log 
phase. Primary astrocytes (10,000 cells/well) were seeded in 24-well plates in 
complete media. After 24 hours, cells underwent serum starvation with 0.1% FBS 
for 48 hours. On day 0, cells were washed with IX PBS twice and incubated in 1, 2 
and 3 mM glucose media. Cell numbers were counted at different time points as 
indicated. Data collected were used for plotting the growth curves and calculating 
the PDT and saturation densities. PDT was calculated using the same formula as 
described for Figure 3.1. Table 3.2 shows the results of the calculation. Three 
independent experiments were performed with similar observations. Data were 
expressed as mean 土 SEM in quadruplicate set up. 
[Glucose] 1 mM 2 mM 3 mM 
Population doubling time 
P ^ 35.96+ 1.66 37.07 + 0.92 42.88 + 3.19 “ “ -
Table 3.2 The PDT of primary astrocytes growing in different glucose 
concentrations. 
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3.1.2 Flow Cytometry Assay 
Cell cycle progression of C6 cells was analyzed by flow cytometery. In order to 
study the effect of glucose deficiency on the growth of C6 cells，cells were incubated 
in different glucose concentrations and fixed at different time points. Although 
there was no significant difference in the population distribution amongst different 
groups in different glucose concentrations, trends were observed. On day 2, when 
cells were in the early log phase, lower glucose concentration gave a higher 
percentage of the population in S phase. On day 10，when cells were in the 
stationary phase, lower glucose concentration gave a lower percentage of cell 
population in the S phase. Such data are consistant with the observation in the 
growth curve studies. Throughout the experiments, apoptotic populations were not 
detected. This could be due to the removal of media along with the floating dead 
cells before harvesting the cells. 
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Figure 3.3 Effects of glucose deficiency on cell cycle progression. C6 cells were 
seeded in the same densities (25 cells/mm ) as in the growth curve study. On day 2 
and 10 corresponding to the growth curve study, cells were fixed with 70% ethanol 
and stored at -20°C overnight. Before the assay, cells were washed with IX PBS 
and subjected to DNA staining and RNA removal by propidium iodide and Rnase A 
treatment. Cell population in different phases of cell cycle were measured by flow 
cytometry. Y-axis represents the percentages of cell population in different phases. 
X-axis represents the day when cells were harvested. Data were expressed as mean 
土 SEM of an experiment in triplican set up. The differences of population 
distribution of cells incubated in 1 mM and 2 mM glucose were compared with that 
of cells growing in 3 mM glucose by the Rank Sum Test. 
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3.1.3 ^H-Thymidine Uptake Assay 
H-thymidine uptake assay is another method to monitor the cell proliferation. 
As thymidine is one of the components of DNA structure, cells with higher 
proliferation rates will incorporate more thymidine for DNA synthesis. The amount 
of incorporated radioactive thymidine is directly proportional to the proliferation 
rates of cells. In order to study the effects of glucose deficiency on DNA synthesis. 
Synchronized C6 cells were incubated in media containing 1% FBS and different 
、 
glucose concentrations in the presence of H-thymidine for 24 hours. Cells 
undergoing S phase during the incubation period took up the radioactive thymidine 
and incorporated them into their DNA. When C6 cells and primary astrocytes were 
exposed to media with different glucose concentrations, the DNA synthesis of cells 
measured in 1 mM glucose was the highest (Figure 3.4). This represented that the 
highest proliferative activity occurred in cells growing in 1 mM glucose as compared 
to 2 mM and 3 mM. Observations of this assay were consistent with those obtained 
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Figure 3.4 Glucose deficiency stimulated DNA synthesis of A) C6 cells and B) 
primary astrocytes. C6 cells (5,000 cells/well) and primary astrocytes (50,000 
cells/well) were seeded in 24-well plates in the complete medium. After 24 hours, 
cells underwent serum starvation by incubating in medium with 0.1% FBS for 48 
hours. On the day of the assay, cells were washed twice with IX PBS and 
incubated in 1，2 and 3 mM glucose media with 1% FBS supplemented with l|iCi/ml 
^H-thymidine for 24 hours. At the end of incubation, cells were washed with ice 
cold IX PBS twice and incubated in ice cold 10% TCA for 1 hour on ice. Cells 
were then washed twice with ice cold 10% TCA to remove unincorporated labeled 
thymidine and lysed with IN NaOH and incubated at 37°C for 2 hours. Cell lysates 
were subjected to scintillation counting. Radioactivity measured were recorded in 
DPM and converted to percentage change relative to the DPM of the control value (3 
mM glucose treated group was set at 100%). Data were expressed as mean 土 SEM 
of pooled data from three independent experiments in quadruplicates setup (n=12). 
‘*’ Represents significant difference (p< 0.05) and ‘**，represents significant 
difference (p< 0.01) between 1 and 3 mM glucose. 
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3.2 The Effects of Glucose Deficiency on Neurotrophic Properties of Glial Cells 
In order to analyze the chronic effects of glucose deficiency on neurotrophic 
properties of glial cells in vitro, cells were allowed to grow in 1, 2 and 3 mM glucose 
media for five days. Two neurotrophic properties of glial cells were analyzed: (1) 
neurotrophins expression and (2) lipid homeostasis. 
The neurotrophin family includes NGF, BDNF, NT-3 and NT-4/5 (Obara and 
Nakahata, 2002). Besides, SIOOB is a neurotrophic factor which can serve as a 
marker for CNS damages (Barger et al.，1995; Rothermundt, 2003). Effects of 
glucose deficiency on transcriptional levels of neurotrophins as well as SIOOB were 
quantified by northern blot assays while the translation levels were quantified by 
western blot assays. 
On the other hand, several genes were chosen for the study of lipid homeostasis, 
including ApoE, HMGCSl, HMG-CoA reductase, FASN and HMGCS2. Their 
mRNA expressions under different glucose conditions were quantified by northern 
blot assays. Cellular and media cholesterol and fatty acids profiles were analyzed 
by GC and GC-MS assays. 
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3.2.1 The Effects of Glucose Deficiency on mRNA and Protein Expressions of 
Neurotrophins 
3.2.1.1 Northern Blot Assays 
Northern blot assay is a direct measurement to compare the amount of mRNA of 
a target gene in different samples. Quantification of the mRNA in different samples 
was achieved by separating total RNA on denaturing agarose gels and transfering to 
nylon membranes followed by cross-linkage. The presence of target RNA was 
hybridized with alkaline phosphatase-labeled DNA probes with sequences 
complementary to the target mRNA sequences. When there were more target 
mRNA present, more probes would be hybridised and retained on the membrane. 
When substrate was added, light was emitted due to the enzymatic reaction. Light 
intensities captured by X-ray films were proportional to the quantities of probe 
present on the membranes. Therefore, mRNA expression levels of the target genes 
can be measured according to the intensity of bands on the films. For quantifing 
purpose, the expression level of each gene was normalized by the light intensity of 
the 'house keeping' gene ((3-actin) level. As determined by northern blot, the 
mRNA expressions of neurotrophins were dependent on glucose concentrations in a 
gene-specific manner (Figure 3.5). 
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The NGF mRNA expression levels change with the glucose concentrations. 
The trends in C6 cells and primary astrocytes were opposite (Figure 3.5A). In C6 
cells，when glucose concentration decreased to 1 mM, NGF mRNA expression 
decreased by 11%. However, in astrocytes, the expression level increased by 113%. 
Two BDNF mRNA transcripts, 1600 bp and 1100 bp, were detected in the assay 
(Figure 3.5B). The 1600 bp transcript expression levels increased in both C6 and 
primary astrocytes when glucose concentration decreased. However, the expression 
of the 1100 bp transcript decreased in C6 cells when glucose concentration decreased 
to 1 mM while it increased in primary astrocytes. 
The expressions of NT-3 transcripts changed with glucose concentrations and 
different trends were observed in the two cell types (Figure 3.5C). The expression 
of the longest transcripts (2300 bp) increased both in C6 cells and primary astrocytes, 
by 44% and 71%, respectively, as glucose concentration decreased from 3 mM to 1 
mM. The expression pattern of 1400 bp and 1000 bp transcripts in primary 
astrocytes and C6 cells were different. These two transcripts only showed a small 
decrease in the expression level in C6 cells when glucose concentrations decreased 
while they increased in expression for 143% and 60% respectively in primary 
astrocytes when glucose decrease from 3 mM to 1 mM. On the other hand, the 
change in expression of the two shortest transcripts, 700 bp and 400 bp, in primary 
astrocytes and C6 cells were similar when glucose concentration dropped. Both 
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transcripts showed trends of decrease in both cell types, with a maximum drop of 
46% in C6 cells and 21% in primary astrocytes，when glucose concentration 
decreased from 3 mM to 1 mM. 
The NT-4/5 mRNA expression increased in both C6 cells and primary astrocytes 
when glucose decreased from 3 to 1 mM (Figure 3.5D). 
The changes of mRNA expression of SIOOB were not the same in C6 cells and 
primary astrocytes when glucose concentration dropped. In astrocytes，a decrease 
in glucose concentration up-regulated the SIOOB mRNA expression while such trend 
was not observed in C6 cells (Figure 3.5E). 
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Figure 3.5 Effects of glucose deficiency on the mRNA expressions of different 
neurotrophins and SIOOB. C6 cells and primary astrocytes were incubated in 
different glucose concentrations for 5 days as described in Methods. Cells were 
lysed with TRI Reagent and extracted with BCR Total RNA integrity was checked 
with native 1% agarose gel electrophoresis before northern blot analysis. Only 
samples with 28S:18S rRNA intensity of 2:1 ratio were used for northern blot 
analysis. 15 ^g of RNA sample was loaded in each lane of gels followed by 
electrophoresis and transfer of samples to a nylon membrane. Nylon membrane 
was hybridized with probes specific toneurotrophins: A) NGF, B) BDNF, C) NT-3, D) 
NT4/5 and E)S100B. The intensities of bands on films were measured by the 
Image J software with background subtraction. The expression levels of the target 
genes were calculated by dividing the light intensities of the target bands by the light 
intensities of B-actin signals. Signals obtained from cells treated under 3 mM 
glucose served as the control value and was set as 1.0. The numbers below the 
photos represent the mean value of the ratio of expression levels of the target genes 
compare to the control value (n=2 for all neurotrophins and n=3 for SIOOB). 
represents significant difference from the control value (p<0.05). 
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3.2.1.2 Western Blot Assays 
Western blot assay provides a method to quantify the amount of target proteins 
present in cells. Proteins in the cells were separated on 16% SDS-polyacrylamide 
gels according to their molecular weights. Then proteins were transferred to 
membranes and incubated with specific primary antibodies. The membranes then 
were incubated with horseradish peroixdase-linked secondary antibodies that bind to 
the primary antibodies with specificity. ECL/M reagent mixtures act as a substrate 
for peroixdase, lights are emitted from enzymatic reactions and signals are captured 
by X-ray films. The signal intensities were measured and quantitied as protein 
expression levels. 
The neurotrophins were detected as pro-NGF，pro-BDNF and pro-NT-3. Mature 
form of neurotrophins were not detected. The expression levels of these proteins 
were not significantly different amongst different glucose concentrations in both C6 
cells and primary astrocytes. There were no observable trends in pro-NGF and 
pro-NT-3 expressions (Figure 3.6 A and C). However, there were opposite trends 
observed in the pro-BDNF quantities in C6 cells and primary astrocytes although 
there are opposite (Figure 3.6B). In C6 cells, the pro-BDNF increased in quantities 
when glucose concentration decreased. In primary astrocytes, the pro-BDNF 
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Figure 3.6 Effects of glucose deficiency on protein expression of different 
neurotrophins. C6 cells and primary astrocytes were incubated in media with 
different glucose concentrations for 5 days as stated in Method. Cells were lysed 
with lysis buffer and 100 |ig of protein were subjected to electrophoresis followed by 
immunoblotting with specific antibodies against various neurotrophins: A) NGF, 
B)BDNF and C)NT-3. The intensities of bands on films were measured with the 
Image J software with background subtraction. The expression levels of the target 
proteins in cells incubated in 1 and 2 mM glucose were compared to that in 3 mM 
glucose which served as a control value whose level was set as 1.0. The values 
below the bands represent the mean value 土 SEM of the expression levels of the 
target protein relative to the control (n=5 for NGF, n=4 for BDNF and n=3 for NT-3). 
The expression values were plotted as bar chat below the photos. 
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3.2.2 The Effects of Glucose Deficiency on Lipid Homeostasis 
3.2.2.1 Northern Blot Assays 
In order to investigate the effects of glucose deficiency on the lipid homeostasis 
in glial cells, the mRNA expressions of enzymes involved in lipid transportation, 
cholesterol synthesis, fatty acids synthesis as well as ketone body synthesis were 
tested using northern blot assays and RT-PCR. 
RT-PCR was employed because it is cost effective, more convenient and much 
time-saving for studying gene expressions. However, all experimental errors, 
including the performance of PCR machine, will be amplified and the data analyis 
would be confounded. Therefore, the data obtained from RT-PCR should only 
serve as supplementary information for comparing the results in the northern blot 
assay. 
Astrocytic ApoE gene expression was tested for four times by northern blot. 
Two independent RT-PCR experiment and one northern blot assay were performed 
for other lipid homeostatic genes (Figure 3.7 and Table 3.3). 
Our data showed a dose-dependent effect of glucose on the mRNA expression 
levels of various genes related to lipid homeostasis. When glucose decreased from 
3 mM to 1 mM, the mRNA expression of ApoE, which is the major lipid-carrying 
protein in the CNS, was up-regulated in both C6 cells and astrocytes by 50% and 
75%, respectively (Figure 3.7A). Besides, the results from RT-PCR showed a 
-96-
consistent observation in C6 cells (Table 3.3). 
Under glucose deficiency, C6 cells and primary astrocytes responded differently 
on the expression of genes in lipid biosynthesis (Figure 3.7 B and C). In the 
cholesterol homeostasis, the mRNA expression levels of HMG-CoA reductase and 
HMGCSl were up-regulated by 72% and 9% respectively in C6 cells as determined 
by northern blot. Consistent with that, results from RT-PCR showed an increase in 
the gene expressions of HMG-CoA reductase by 57% and HMGCSl by 31% (Table 
3.3). In astrocytes, northern blot analysis showed a 9% decrease in the HMG-CoA 
reductase gene expression when the glucose concentration decreased from 3 mM to 1 
mM. However, a dose-dependent increase was observed in the mRNA expression 
HMG-CoA reductase as determined by RT-PCR. The discrepancy between the 
results obtained from RT-PCR and northern blot assay suggests that further 
experiments are required to reach a conclusion on glucose regulation of HMG-CoA 
expression in astrocytes. On the other hand, northern blot showed a 
down-regulation of the HMGCSl mRNA expression by 74% in primary astrocytes, 
and this observation was reproducible in the RT-PCR experiment (Table 3.3). 
Fatty acid synthase, which involves in the fatty acid homeostasis, was found to be 
up-regulated in C6 cells by 67% and in primary astrocytes by 174% under glucose 
deficiency as shown by northern blot (Figure 3.7D). These observations were 
reproducible in the RT-PCR experiment. 
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As determined by northern blot, the gene expression of HMGCS2, which is an 
essential enzyme for ketone body synthesis, was down-regulated by 18% in C6 cells 
and 74% in astrocytes (Figure 3.7E). The results obtained in C6 cells were 
consistent to that in the RT-PCR experiment (Table 3.3). However, for the 
astrocytic HMGCS2, large discrepancies were obtained from the two independent 
RT-PCR experiments. Thus, only results from northern blot would be employed for 
data interpretation of HMGCS2. 
s 
Therefore, C6 cells showed that lower glucose concentration up-regulated the 
gene expression of the enzymes involving cholesterol synthesis while primary 
astrocytes showed no obvious change in the HMG-CoA reductase mRNA expression 
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Figure 3.7 Effects of glucose deficiency on mRNA expression of genes involved 
in lipid homeostasis. C6 cells and astrocytes were incubated in media with 
different glucose concentrations for 5 days as stated in Method. Cells were lysed 
with TRI Reagent and extracted with BCP. Total RNA integrity was checked with 
native 1% agarose gel electrophoresis before northern blot analysis. Only samples 
with 28S:18S rRNA intensity of 2:1 ratio were used for northern blot analysis. 15 
^g of RNA sample was loaded in each lane of gels followed by electrophoresis and 
transfer of samples to a nylon membrane. Nylon membranes were hybridized with 
DNA probes specific to the target genes: A) ApoE, B) HMG-CoA reductase, C) 
HMGCSl, D) FASN and E) HMGCS2. The intensities of bands on films were 
measured by the Image J software with background subtraction. The expression 
levels of the target genes were calculated by dividing the light intensities of the target 
bands by the light intensities of 6-actin signals. Signals obtained from cells treated 
under 3 mM glucose were served as the control value and was set at 1.0. The 
numbers below the photos represent the ratio of expression levels of the target genes 
when compare to the control value (n=4 for ApoE in astrocytes and n=l for others). 
C6 Astrocytes 
[Glucose]/mM 1 2 3 1 2 3 
ApoE 1.53 1.36 1.00 - - -
HMG-CoA 127 i.oo 1.12 1.24 1.00 
reductase 
HMGCSl 1.31 1.07 1.00 0.57 0.94 1.00 
FASN 1.85 1.40 1.00 1.63 1.53 1.00 
HMGCS2 0.48 0.92 1.00 0.48 1.46 1.00 
Table 3.3 Semi-quantitative RT-PCR analyses on the expression of genes related 
to lipid homeostasis under glucose deficiency. RNA samples were collected by 
the same was as the northern blot assays. 5 jxg RNA was subjected to reverse 
transcription (RT) reaction with 20 \i\ reaction volume. After RT reactions, the 
cDNA sample was diluted to 10 times. 5|il of diluted cDNA was submitted for PCR 
with 25^1 reaction volume. Annealing temperature for ApoE primers were 60°C 
with 1 minute extension time with the reaction ran for 33 cycles. Annealing 
temperature was 55°C with 1 minute extension time for other primers sets, HMGCSl 
reaction was proceeded for 37 cycles, HMG-CoA reductase for 28 cycles, FASN for 
33 cycles and HMGCS2 was for 40 cycles for detection of the gene expression. 
Data are expressed as mean of two independent experiments (n=2). '-'represents no 
reaction was performed. 
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3.2.2.2 Gas Chromatography Assays 
Gas chromatography assay is a sensitive method for separating and quantifying 
different lipid species. Lipids in samples were extracted with a series of steps using 
various organic solvents as described in Chapter 2. Since cholesterol and fatty acids 
have different chemical properties, they were analyzed in separate experimental 
set-up and exaction methods. Both methods require the conversion of components 
into the more volatile states. Trimethylsiyl (TMS) reagent Sigma-Sil-A was used as 
the methylating agent for cholesterol derivatives formation while toluene with 
boronfluoride in 12% methanol was used for the formation of various fatty acid 
derivatives. When samples were injected into the columns, chemicals with different 
motilities can be detected at different time points by the detector at the end of 
columns. The detector then converted signals into peaks, and the quantities of 
cholesterol and fatty acids were calculated by comparing the peak areas with that of 
the internal standards. Identities of fatty acids were performed by MSD with the 
help of a compound library and software provided by the GC-MSD manufacturer. 
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3.2.2.2.1 Chokstero 丨 Analyses 
In C6 cells, the total amount of cholesterol detected in the media was increased 
significantly when glucose concentration decreased from 3 mM to 1 mM (Figure 3.8). 
Such observations sustained when the amounts of cholesterol in media and in cells 
were examined separately. The media cholesterol level in 1 mM showed a nearly 
2-fold increase while the cellular cholesterol level increased 47%. 
In contrast, there was no significant change of total cholesterol detected in 
primary astrocytes incubated in different glucose concentrations (Figure 3.9). 
When media and cellular cholesterol were examined separately, the media 
cholesterol showed a 24% increase as glucose concentration decreases from 3 mM to 
1 mM. However, such increase did not reach statistic significance. On the other 
hand, cellular cholesterol was slightly decreased but the decrease was also 
insignificant. Therefore, there was no significant effect of glucose deficiency on the 
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Figure 3.8 Glucose deficiency increased cholesterol quantities in C6 cells and 
media. A) Total amount of cholesterol of C6 cells. B) Cellular and media 
cholesterol of C6 cells. C6 cells were incubated in different glucose media with 1% 
FBS for 6 days with media change on day 3 and 5. The media and cells were 
collected separately. Lipids were extracted and subjected to GC analysis. The 
quantity of cholesterol in each sample was calculated by dividing of the cholesterol 
peak area by the peak area of internal standard and multipling the weight of internal 
standard. The content of cholesterol was normalized by the amount of total cell 
protein. 3 mM glucose concentration was taken as the control value set at 100%. 
All values were then converted to percentage change against the control value. 
Data are expressed as the percentage value of mean 土 SEM (n=9) of three 
independent experiments in triplicated set up. Represents significant difference 
from control value (p< 0.05). 
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Figure 3.9 Glucose deficiency had no significant effect on primary astrocytes. 
A) Total cholesterol of primary astrocytes. B) Cellular and media cholesterol of 
primary astrocytes. Primary astrocytes were incubated in different glucose media 
for 6 days with media change on day 3 and 5. The media and cells were collected 
separately. Lipids were extracted and subjected to GC analysis. The quantity of 
cholesterol in each sample was calculated by dividing of the cholesterol peak area by 
the peak area of internal standard and multipling the weight of internal standard. The 
content of cholesterol was normalized by the amount of total cell protein. 3 mM 
glucose concentration was taken as the control value set at 100%. All values were 
then converted to percentage change against the control value. Data are expressed 
as the percentage value of mean 土 SEM (n=9) of three independent experiments in 
triplicated set up. 
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3.2.2.2.2 Fatty Acid Analyses 
The effects of glucose deficiency on the change of fatty acid homeostasis were 
more obvious in C6 cells than in primary astrocytes (Figure 3.10，Figure 3.11 and 
Table 3.4A and B). In C6 cells, when glucose concentration decreased from 3 mM 
to 1 mM, the total media and cellular fatty acids were significantly increased (Figure 
3.10). The extent of the increase in fatty acid amount was found the greatest in the 
media without serum in 1 mM glucose. For primary astrocytes, there was no 
V 
significant difference in the change of total fatty acid content amongst different 
glucose concentrations (Figure 3.11). 
Glucose deficiency also has significant effects on the fatty acid profiles of C6 
cells, but the effect did not reach statistic significance in primary astrocytes. 
In C6 cells, when glucose concentration was decreased from 3 to 1 mM, AA 
was significantly increased in both media and cells except that AA was undectable in 
medium containing no serum. Arachidic acid was also significantly increased in 
media (1 and 0% FBS) and cells (1% FBS). 
In primary astrocytes, although the difference between the data of different 
glucose concentrations did not reach statistic significance, both media and cellular 
AA contents increased when glucose concentration. 
Although there are trends of change in quantities of other fatty acids under the 
change of glucose concentration, they do not reach statistic significance. 
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Figure 3.10 Glucose deficiency increased fatty acid quantities in C6 cells. A) 
Total fatty acid in media of C6 cells without FBS. B) Total cellular fatty acid in C6 
cells without FBS. C) Total fatty acid in media of C6 with 1% FBS. D) Total 
cellular fatty acid in C6 cell 1% FBS. C6 cells were incubated in different glucose 
media for 6 days with media change on day 3 and 5. The media and cells were then 
collected separately. Lipids were extracted and submitted to GC-MS assay. The 
quantities of various fatty acids in each sample were calculated by comparing to the 
quantity of the internal standard. Total fatty acid amounts were calculated by 
summing the amount of various fatty acids species and divided by the amount of 
total cell protein. The values of cells incubated in 3 mM glucose concentration 
were used as the control (set at 100%). All values were then converted to 
percentage value relative to the control value. Data are expressed as mean 土 SEM 
(n=9) of three independent experiments in triplicate setup (Table 3.4A and B). '*' 
represents significant difference from control value (p< 0.05). 
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Figure 3.11 Glucose deficiency media had no significant effect on fatty acid 
homeostasis of primary astrocytes. A) Total fatty acid in media of primary 
astrocytes without FBS. B) Total cellular fatty acid in the cells of primary astrocytes 
without FBS. C) Total fatty acid in media of primary astrocytes with 1% FBS. D) 
Total cellular fatty acid in the cells of primary astrocytes with 1% FBS. Primary 
astrocytes were incubated in different glucose media for 6 days with media change 
on day 3 and 5. The media and cells were then collected separately. Lipids were 
extracted and submitted to GC-MS assay. The quantities of various fatty acids in 
each sample were calculated by comparing to the quantity of the internal standard. 
Total fatty acid amounts were calculated by summing the amount of various fatty 
acids species and divided by the amount of total cell protein. The values of cells 
incubated in 3 mM glucose concentration were used as the control (set at 100%). 
All values were then converted to percentage value relative to the control value. 
Data are expressed as mean 土 SEM (n=9) of three independent experiments in 
triplicate setup (Table 3.4A and B). ‘*, represents significant difference from 
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1 i Growth curve study T T 
. J 
^ g) Flow cytometry T nil 
1 。 
0 H-thymidine uptake 丨 ^ 
assay 
mRNA Proteins mRNA Proteins 
^ NGF i T ^ § 
•ffl ^ BDNF1600 bp T T . 
T i 
BDNFllOO bp i T 
1 _ 1 _ 攀 NT-3 2300 bp t T 
NT-3 1400 bp i T 
"g I NT-3 1000 bp i ^ T ^ 
l l l p f c NT-3 700 bp i i 
_ _ _ _ 國 NT-3 400 bp i i 
NT-4/5 T nil T nil 
SIOOB B^imBI^^BIHII^^^^B 
^ C6 Primary astrocytes 
••ittillM^^^^ 丨…........”.、:.‘.、:.:.™.:.:.:‘:.—丨… 
ApoE T * T 
msSl^umm 
l | i i l _ i | _ l _ l l l HMG-CoA reductase T ^ 
^ i 5 
^ ^ HMGCSl T i < ts 
FAS t t 
_ 1 _ 1 _ 圖 ^ HMGCS2 i i 
• H i i i m i i i i H M O T M M i i M M ________ 
I l i l l l M ^ Media Cell Media Cell 
(1%FBS) (1% FBS) (1%FBS) (1% FBS) 
llllil^^^^ Cholesterol T * t * 分 ^ Immmmi^mmMrnM 
Total FA T ^ 矜 
_ _ _ 圖 ^ AA — T T^ T T 
WK^^K^M Arachidic acid T * T T 
Table 3.5 Glucose deficiency modulates growth, lipid profiles and neurotrophic 
factor expression profiles. ‘Nil’ represents no experiment was performed. 
‘ T 'represents an increasing trend was observed when glucose concentration 
decreased. ‘ i 'represents a decresing trend was observed when glucose 
concentration decrease. ‘—，represents no trend was observed when glucose 
concentration decrease, 'nil' represents no value is available. 'represents 
significant difference (p<0.05). 
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Chapter 4 Discussion 
4.1 The in vitro Model of Hypoglycorrhachia 
Due to the multifaceted functioning of glucose in biochemical pathways, the 
effects of glucose deficiency can be widespread in cells. Although the effects of 
glucose deprivation on cell proliferation, toxicities and apoptosis of the cells in the 
nervous system have been studied before (Russo et al, 2004; Martinez-Sanchez et al., 
2004; Kansara and Berridge, 2004; Ishii et al” 2004), most of the conditions used in 
these experiments mimicked the ischemia state. In addition, many of these studies 
adopted glucose concentration as high as 25 mM in the media. The results obtained 
from these ischemia experiments might not be applicable to the diseases associated 
with chronic glucose deficiency states. In fact, there are only very few studies 
examining the relationship between glucose concentrations and the functioning of 
brain cells. 
We have established an in vitro system to study the properties of glial cells 
under the physiological and pathological range of glucose concentrations. Since at 
the normal physiological state, the glucose concentration in endothelial cells is 3 mM, 
and in CSF is 2.7 mM (Duelli and Kuschinsky, 2001), cells incubated in 3 mM 
glucose was considered as in normal glucose level and data were used as the control 
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value. As CSF glucose concentration of 2.2 mM (40 mg/dl) causes 
neuroglycopenic symptoms in patients with hypoglycemia (Carroll et al., 2003), cells 
incubated in 2 and 1 mM, were used to model the hypoglycorrhachia states. 
Two cell types were used in this study: C6 cells and primary astrocytes. C6 
cells are glioma cells induced by the injection of A^-nitrosomethylurea in rats (Benda 
et aL, 1968). Although C6 cells are transformed glioma cells, they have been used as 
astrocyte models in many studies to demonstrate the responses of glial, such as 
antigen properties, enzymatic features, response to hormones and stress, growth and 
metabolism under various pathological and tocxicity conditions (Khan et aL, 1998; 
Kumar et al, 1984; Antonow et aL, 1984; Goldman and Chiu, 1984). On the other 
hand, C6 cell line is not difficult to maintain and the proliferation rate is high. 
Therefore, it was used as one of the glial cell models in the current study. In order 
to obtain more relevant information on the in vivo condition, primary astrocytes 
culture was also introduced. 
In addition, we did not use 10% v/v FBS like in many other experimental 
settings. Since FBS contains certain amount of glucose (around 1,250 mg/dL) and 
other steroids and hormones that are necessary for cell viability (Price and Gregory, 
1982), large quantities of FBS will confound our observations. By reducing the 
FBS to 1%, the confounding effects of serum growth factors on glial cell responses 
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can be minimized. 
4.2 Decreased Glucose Level Triggers Changes of Gial Cells Proliferation 
Many previous studies have demonstrated that glucose plays a critical role in 
regulating cell proliferation. For example, lack of D-glucose in the media induces 
cell cycle arrest in yeast (Newcomb et al., 2003). Decreasing the media glucose 
concentration to only half of the physiological concentration (50 mg/dl，2.8 mM) 
reduced the proliferation of human lymph node metastasis and completely inhibited 
human brain metastasis cell proliferation when glucose is lower than 100 mg/L (0.56 
mM) (Singh et al, 1999). However, there had been no solid report showing the 
direct relationships of glucose concentrations and growth properties of glia cells 
within the range of normal to hypoglycorrhachia CSF glucose level. 
This is the first report showing how the decreasing of glucose concentrations 
from physiological to hypoglycorrhachia range affects the proliferation rates of glial 
cells. In the growth curve studies, the numbers of both C6 cells and primary 
astrocytes at 3 mM glucose were relatively lower than the number of cells exposed to 
1 mM glucose throughout the first four days, while the growth curve from cells in 2 
mM glucose fall in between. This indicated that a higher proliferation rate occurred 
in 1 mM glucose. The flow cytometry assay of C6 cells also showed a trend of 
increase in cell population in the S phase at the early log phase as glucose 
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concentration decreased. Due to the relative small change of cell proliferation 
amongst the tested groups, not all data points in the experimental groups were 
significantly different than the control values. However, such effect was 
reproducible. In addition, as compared to the of cells grown in 3 mM glucose, 
^H-thymidine uptake assay showed significantly higher DNA synthesis activities in 
both cell types incubated in lower glucose concentrations. In summary, glucose 
deficiency stimulated the proliferation of primary astrocytes and C6 cells in the early 
log phase. 
Since DNA synthesis requires glucose to provide the substrate and energy, the 
decrease in glucose supply in the medium should decrease DNA synthesis. 
However, the data showed that decrease in glucose concentration induced DNA 
synthesis instead. It is speculated that other components, such as glutamine and 
other amino acids, in the media might compensate for the decrease of glucose for 
DNA synthesis. Furthermore, the extra energy required might be derived from the 
amino acids. 
In the saturation phase of the growth curve study of C6 cells，cells stopped 
increasing in number eventually although they did not fill up all the space on the 
plates and remain in monolayer. Meanwhile, the flow cytometry assay showed a 
smaller cell population accumulated in the S phase in the saturation state as glucose 
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concentration drops. In addition, the preliminary result of trypan blue viability test 
showed no significant difference except on day 7 in the number of cell deaths 
amongst different glucose concentrations throughout the time course (Figure A.l, 
Appendix). Therefore, the lower saturation density of cells in lower glucose 
concentration is not due to higher death rate but may due to lower proliferation rate. 
At this stage, C6 cells may have reached a point at which cell proliferation rate 
balanced the death rate as cell numbers remained consistence from day 7 to day 9. 
It is speculated that the lower saturation densities of C6 cells in lower glucose 
concentrations might be due to the limitation of nutrient supply. However, the 
concentrations of glucose in the media were not measured at the end of incubation, 
and there could be excessive amino acid like glutamine which can also enter the 
tricarboxylic acid for ATP production, and there may be other reasons causing the 
drop of saturation density when glucose concentrations drop. From the growth 
curve study, C6 cells grew differently under different glucose concentrations at 
different growth phase. This implies that glucose regulates the growth of C6 cells 
in a growth phase dependent manner. 
For primary astrocytes, the cell numbers decreased after 6-day incubation, thus 
the saturation density could not be determined. The decrease of cell number may be 
due to the cell death. However, whether the cells undergo necrosis or apoptosis 
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remains to be further analysed. The possibility of cell death after prolonged 
exposure to glucose deficiency in primary astrocytes cannot be excluded� 
The occurrence of changes in the proliferation rate and changes of saturation 
densities under the changes of glucose concentrations may indicate changes of glial 
cell functions (Eng and Ghirnikar, 1994，Wu and Schwartz, 1998; Saravia et al, 2002; 
Sharma et al., 2003, Aschner et al., 2002). Therefore, our studies showed that the 
decrease of glucose level in CSF might cause altered functional responses of glial 
cells. One of the important roles played by glial cells in the brain is the production 
neurotrophic factors. Therefore, the production of neurotrophins has been defined 
at transcription and translation levels in glial cells exposed to glucose deficiency. 
4.3 Expression of Neurotrophic Factor under Glucose Deficiency 
4.3.1 Alteration of the Expression of Neurotrophins 
We evaluated the expression and regulation of the neurotrophins NGF, BDNF， 
NT-3 and NT-4/5 under glucose deficiency. 
The expression of neurotrophins in hippocampus is regulated by various factors 
around the neuronal cells and glia cells where they were synthesized (Wu et al., 
2004). Expression of neurotrophins is tightly regulated in all tissues. Promoter 
multiplicity and transcript diversity are the common features of gene organization in 
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this family (Bertaux et al., 2004; Heinrich and Pagtakhan, 2004). Each 
neurotrophin is regulated by more than 2 promoters which in turn give several forms 
of transcripts. Due to the complexity of the promoter structures and the regulatory 
mechanisms, the developmental and cell-specific expression are not well understood. 
The regulation of each neurotrophin by chemicals has been studied in various 
conditions before, such as BDNF expression is regulated by calcium (West et al, 
2001) and dopamine signaling (Fang et al., 2003), while NT-3 expression is 
down-regulated in the rat hippocampus after transient forebrain ischemia (Takeda et 
al., 1992). Furthermore, the expression of each neurotrophin is differentially 
regulated by neuronal signals (Wu et al” 2004). Addition of different neurotrophins 
modulate survival and energy metabolism of neurons and all four neurotrophins 
increase neuronal survival after hypoglycemic stress in in vitro systems (Nonner et 
al., 1996; Takman et al” 2004; Tong and Perez-Polo, 1998; Boniece and Wagner, 
1995 ). For example, the addition of NGF protects PC12 cells against ischemia by a 
mechanism that required the N-kinase. BDNF protects neurons in the hippocampus 
septum and neocortex from glucose deprivation-induced damage (Kokaia et al., 1994; 
Cheung and Mattson, 1994). NT-3 protects neuronal cells from death induced in 
cerebral ischemia, oxygen-glucose deprivation, and oxidation which could involve 
oxygen free radicals (Bates et al., 2002). Meanwhile, NT-4/5 protects cultured 
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embryonic rat hippocampal and cortical neurons against glucose deprivation-induced 
injury (Cheng, 1994). On the other hand, exogenous BDNF stimulates glucose 
utilization and neuronal glucose transporter Glut3 in response to an enhanced energy 
demand resulting from increases in amino acid uptake and protein synthesis 
associated with the promotion of neuronal differentiation by BDNF (Burkhalter et al, 
2003). 
Although many reports showed the ability of enhancing neuronal survival 
during glucose deprivation with addition of neurotrophins, there have been no 
previous studies reporting the effects of glucose deficiency on the production of 
neurotrophins by astrocytes. Since astrocyte is a site of neurotrophin production, it 
is necessary to study the change of neurotrophin synthesis in astrocytes when glucose 
concentration is changed. We have demonstrated the effects of glucose 
concentrations (1, 2 and 3 mM) on the regulation of neurotrophins expression. 
4.3.1.1 NGF 
The NGF gene is also known as NGF beta. It is composed of a 5' exon and a 
3，exon separated from a 40 kb introns and alternatively spliced to produce a number 
of differentially sized mRNAs (Cartwright et al., 1992; Zheng and Heinrich, 1988; 
Cartwright et aL, 1992). However, there is limited information about the total 
number of transcripts of NGF because of the alternative splicing (Bertaux et al., 
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2004). In spite of the number of transcripts of NGF, there is no major change of the 
final translation product, 35 kDa pro-NGF，for the various transcripts containing a 
complete coding region (Seidah et a.I, 1996; Bertaux et al., 2004). 
In our studies, only one transcript around 900 bp was detected. The change in 
the mRNA expression of NGF was different in C6 cells and primary astrocytes when 
glucose concentration was changed. Although there was no significant change in 
the mRNA and protein expression at different glucose concentrations in both cell 
types, trends were observed. The mRNA expression of NGF showed a decreasing 
trend in C6 cells when glucose decreased while it showed an increasing trend in 
astrocytes. However, there was no observable trend found in the expression of 
pro-NGF protein in both cell types. Therefore, glucose deficiency affects NGF 
gene transcription but not the translation in a cell specific manner. 
4.3.1.2 BDNF 
There have been at least eight transcripts of BDNF found previously (Poulsen et 
al” 2004). The existence of multiple transcripts is due to the presence of four short 
5' exons, each controlled by a distinct promoter, and one 3’ exon encoding the BDNF 
protein (Figure 4.1) (Givalois et aL, 2001; Timmusk et al., 1993; Nakayama et al., 
1994). The four promoters direct the expression of the BDNF gene in a 
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tissue-specific manner (Mowla et al.’ 2001). Differentiate activation of these 
promoters and alternative splicing results in four transcripts. In addition, each 
transcription unit uses two different polyadenylation signals in the 3'exon that 
together generate eight distinct transcripts encoding an identical pro-BDNF protein 
(Timmusk et al., 1993). The 28 kDa pro-BDNF undergo N-glycosylation that is 
important for stabilizing the pro-BDNF and become a 32 kDa precursor (Mowla et 
al., 2001). The precursor undergoes N-terminal cleavage within the trans-Gogi 
network and immature secretory vesicles to generate mature BDNF with molecular 
weight 14 kDa. 
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Figure 4.1 Schematic diagram of the structure of the BDNF gene and its 
transcripts. The five exons of the BDNF gene are shown by boxes. The four classes 
of BDNF transcripts derived from the BDNF gene are shown in the bottom (Givalois 
et al., 2001). 
In our studies, only two BDNF transcripts, 1600 bp and 1100 bp, were detected 
in both cell types. There was no significant difference of the BDNF expression 
level with the treatment of different glucose concentrations, but trends were observed. 
Both cell types showed increased expression of the 1600 bp transcripts when glucose 
decreased from 3 mM to 1 mM. The 1100 bp transcript, however，was expressed 
with an opposite trend in the two cell types in different glucose concentrations. The 
different expression profiles of the 1600 and 1100 bp transcripts in C6 cells imply 
that they are regulated independently by glucose or it might be that they are driven 
by different promoters. However, since the probe was specially designed to 
hybridise on the exon V where coding region was found, the identities of the 
transcripts were not known and the identities of the promoters cannot be predicted. 
On the translation level, only the pro-BDNF (32 kDa) was detectable while the 
mature BDNF (14 kDa) was not. The expression of pro-BDNF changed with 
glucose concentration, but the trend was different from the transcription level. The 
data reveals that pro-BDNF increased in expression in C6 cells but decreased 
significantly in primary astrocytes when glucose decreased. The expression of 
mRNA and protein of BDNF was regulated differently and previous reports also 
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showed that the mRNA expression was not always consistent with the translation 
level (Jacobsen and Mork, 2004). As the proform of BDNF can be secreted and 
cleaved extracellularly to form the mature BDNF that can modulate the synaptic 
plasticity and long term potentiation (LTP) (Lee et al., 2001; Pang et al., 2004), 
alteration of pro-BDNF production under glucose deficiency would affect the 
neuronal responses. 
4.3.1.3 NT-3 
NT-3 has been shown to contain two 5' exons (exon lA and exon IB) each 
linked with distinct promoters and one 3’ exon (exon 2) containing the coding 
reagion. These two 5'exons are alternatively spliced to generate several transcripts 
(Figure 4.2). All transcripts translate the same pro-NT-3 protein. It has been 
reported that NT-3 is expressed in most tissues including astrocytes in low levels 
(Kendall et al, 2000). 
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Figure 4.2 Structure of the NT-3 gene and its transcripts. The three exons of NT-3 
gene are shown by boxes. The three class of NT-3 transcripts derived from NT-3 
gene are shown in the bottom (Kendall et al, 2000). Transcript l A is due to the 
alternative splicing of exon l A and exon 2 and transcript IB is spliced from IB and 
exon 2. 
In our studies, the expression of NT-3 mRNA was also relatively low. More 
than 40 cycles were required to detect NT-3 using PCR while BDNF was easily 
detected after 32 cycles. Despite the low expressions of NT-3, five transcripts were 
detected. The expressions of the transcripts were different when glucose 
concentration changed. The longest transcript 2300 bp was up-regulated in both cell 
types when glucose concentration decreased. The two shortest transcripts, 700 and 
400 bp, were slightly down-regulated in both cell types. The 1400 and 1000 bp 
transcripts were down-regulated in C6 cells while they were up-regulated in primary 
astrocytes. These observations suggested that the production and splicing of the 
transcripts might be regulated independently by glucose in both cell types. 
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However, there was no observable trend in the change of the expression of pro-NT-3 
in different glucose concentrations. Therefore, glucose deficiency affects NT-3 
gene transcription but not the translation in a cell specific manner. 
4.3.1.4 NT-4/5 
Like other neurotrophins, NT-4/5 is under the regulation of multiple promoters 
and gives multiple transcripts (Ip et aL, 1992). However, in our studies, there was 
only one transcript, around 4800 bp, detected. Similar to the expression of NT-3, 
more than 40 cycles was required for the detection in PCR. In the northern blot 
analysis, the mRNA expression was up-regulated when glucose decreased. 
From our data, we found that glucose regulated the expression of mRNA and 
proteins of neurotrophins differently. This may be due to the different responses of 
different promoters towards glucose. Amongst the three neurotrophins tested on 
protein expression level, only BDNF gave an observable trend when glucose 
concentration changed. But the response is cell type specific. 
4.3.2 Alteration of the mRNA Expression of Calcium Binding Protein SIOOB 
SIOOB is a calcium-binding protein mainly produced by astrocytes 
(Rothermundt et al., 2003). Brain trauma and ischemia are associated with 
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increased SIOOB expression (Baydas et al., 2003). This enhanced CSF SIOOB 
becomes a biological marker of brain damages associated with ischemic stroke or 
cerebrovascular accident (Lamers et al., 1995; person et al., 1987; Aurell et al； 
1991). Previous experiments have demonstrated that SIOOB is a trophic factor for 
several neuronal populations (Azmitia et al” 1990; Eriksen and Druse, 2001). 
Addition of SIOOB in a nanomolar range exerts a neuroprotective effect on neurons 
with glucose deprivation (Barger et al., 1995). SIOOB exerts its effects by 
enhancing the elevations of Ca^ "^  of depolarization, and decreasing the cell death and 
loss of mitochondrial function resulting from glucose deprivation. The increase in 
SIOOB is believed to be a part of response designed to minimize the brain damage 
(Barger et al., 1995). 
In our studies, SIOOB mRNA expression was enhanced in primary astrocytes 
when glucose concentration decreased from 3 mM to 1 mM. In contrast, there were 
slight decreases of SIOOB presented in C6 cells when glucose concentration 
decreased. This implies that when glucose decreases, primary astrocytes would 
initiate a neurotrophic response by increasing SIOOB while C6 cells do not. The 
increase of SIOOB protein production in micromolar range acts as a neurotrophic 
factor. However，when the SIOOB is produced in large quantities up to a 
micromolar range, neurodegeneration may occur (Rothermundt et al, 2003). 
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In the studies of neurotrophic factor productions, it was found that each 
neurotrophic factor was regulated by glucose in a gene and cell specific manner. 
Although C6 cell line was widely used as an astrocyte model and its behaviour is 
comparable to astrocytes, it is not surprising that C6 cells response differently from 
the primary astrocytes in the current studies. It is because C6 cells are derived from 
glioma cells which have lost some of the normal functions of the original cell types 
which it is derived from. 
4.4 Alteration of Lipid Metabolism in Decreased Glucose Supply 
The mammalian brain is the tissue with the highest lipid content besides 
adipocytes. Lipid synthesis and metabolism become a critical event for brain 
development. Since glucose is metabolized to produce acetyl-CoA for the synthesis 
of cholesterol and fatty acids (Figure 4.3), we expected that the availability of 
glucose might affect the provision of lipid to neuronal cells and primary astrocytes. 
Therefore，cell lipid homeostasis was studied. 
Cholesterol and fatty acid are important factors for brain functioning because 
they constitute membrane components that determine the fluidity of cell membrane 
(Spector and Yorek, 1985). The lipid raft is especially rich in cholesterol which 
determines the localization and distribution of receptors (Brown and London, 1998; 
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Ikonen, 2001; Simons and Ehehalt, 2002). The rate of cholesterol synthesis and 
content is therefore important for the brain development where massive signal 
transduction occurs (Dietschy and Turley, 2001; Turley, 1998). 
Cholesterol synthesis has been detected in glial cells and embryonic neurons 
previously (Tabernero et al, 1993; Vance et al., 1994; Chaves, 1997). Although 
neurons require cholesterol for synapse formation, there is a higher cholesterol 
synthesis rate up to seven folds observed in astrocytes (Goritz et a.l, 2002; Vance et 
al., 1994; Saito et al., 1987). It was found that neurons rely on astrocytes for lipid 
synthesis and import the astrocytic products for more cost effective energy 
metabolism. Neurons acquire cholesterol, phospholipids and fatty acids by 
endocytosis of ApoE-associated lipoprotein that is mainly produced by astrocytes 
and is the major lipid carrier in the CNS. Neurons internalize ApoE containing 
lipoprotein via the LDL receptor-related protein 1, very low-density lipoprotein 
receptor (VLDLR) and the ApoE receptor 2 (Herz and Bock 2002; Trommsdorff et 


































































































































































































































































































































































































































































































































































































4.4.1 Up-regulation of ApoE mRNA Expression in Glucose Deficiency 
Among the apolipoproteins in the CNS, ApoE is the dominant lipid transporter 
from astrocyte to neuron. The mRNA expression of ApoE in C6 cells and primary 
astrocytes were analyzed in the current studies. Interestingly, when glucose 
decreased from 3 mM to 1 mM, ApoE mRNA expression was enhanced in both cell 
types. Thus we have demonstrated that there is a glucose concentration dependent 
regulation of ApoE mRNA expression. 
Since ApoE is responsible for lipid transport from glia cells to neurons in the 
CNS, the up-regulation of ApoE mRNA may be associated with the change of lipid 
metabolism in glial cells. Therefore, the contents of cholesterol and fatty acids in 
both C6 cells and primary astrocytes were tested. 
4.4.2 Cholesterol Homeostasis in Glial Cells 
Previous studies have demonstrated that the cholesterol provided from 
astrocytes is an essential factor for synaptogenesis (Mauch et al., 2001) and 
cholesterol in the brain is produced by de novo biosynthesis (Emmond et aL, 1991). 
Evidence showed that when H-cholesterol concentration in milk feeding to rats was 
enhanced, the concentration of H-cholesterol in lung and liver and red blood cells 
of developing rats was significantly increased. In contrast, very little 
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H-cholesterol was detected in the brain. This experiment demonstrated that the 
sterol composition of brain is not influenced by the concentration of cholesterol in 
milk, and further implied that cholesterol in blood does not enter into the brain 
(Edmond et al., 1991). Furthermore, using ^H-water to label the brain cholesterol 
showed that the rate of newly synthesized cholesterol closely followed the rate of 
the total synthesized cholesterol in all brain regions at different time intervals 
(Jurevics and Morell, 1995). These experiments revealed that all the brain 
cholesterol is synthesised de novo and thus it depends on the availability of the 
substrates in the CNS for the synthesis. 
All 27-carbon atoms of cholesterol come from acetate. The condensation of 
acetyl-CoA gives acetoacetyl-CoA and is converted into HMG-CoA by HMGCSl. 
Then it comes to the rate-limiting step in the conversion of HMG-CoA to 
mevalonate which is then finally used for cholesterol synthesis. 
In our studies, we have demonstrated that when glucose concentration 
decreased, HMGCSl and HMG-CoA reductase mRNA expression were 
up-regulated in C6 cells while HMGCSl was down-regulated in primary astrocytes. 
In the GC studies of C6 cells, data supported that when glucose concentration 
decreased from 3 to 1 mM, the media and cellular cholesterol were increased and 
this observation was associated with higher total cholesterol content. As 
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cholesterol is an important component for neuronal differentiation, the increase or 
steady supply of cholesterol by glial cells under nutritional stress may be a 
neuroprotective mechanism. The substrates for cholesterol synthesis may be 
derived from the amino acids in the media. 
On another hand, the primary astrocytes were less responsive than C6 cells. 
The GC data of cholesterol homeostasis of primary astrocytes did not associate to 
the observation of the down-regulated expression of HMGSCSl in cholesterol 
synthesis. There was no difference in the media or cellular cholesterol contents 
amongst the groups under different glucose concentrations. The different 
responses of C6 cells and primary astrocytes may be due to differences between 
glioma and normal cells. 
4.4.3 Fatty Acids Homeostasis in Glial Cells 
Like cholesterol, fatty acids are also important for mental development. 
Previous reports demonstrated that non-essential fatty acids in the brain are 
produced by de novo biosynthesis (Marbois et al., 1992; Edmond et al., 1998). 
The studies involved feeding developing rats with H-fatty acids, ie., palmitic, 
stearic，oleic, linoleic, and linolenic for a period of time. Quantification of these 
isotopomers allows the estimation of the uptake and de novo synthesis of these fatty 
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acids. ^H-palmitic, ^H-stearic and ^H-oleic acids have been found in the liver, lung 
and kidney, but not in the brain. On the contrary, ^H-linoleic acids have been found 
• 2 
in all these organs including the brain. However, recycled all H-fatty acids were 
found in the brain instead. Therefore, the major saturated and monounsaturated 
fatty acids in brain lipids are produced locally by de novo biosynthesis (Edmond, et 
al., 1998). However, long chain polyunsaturated fatty acid cannot be formed by de 
novo pathway (Bourre et al., 1990). They are synthesized from the essential fatty 
acids，linoleic acid (LA) and alpha-linolenic acid (ALA) (Figure 4.4) (Haag, 2003). 
These parent fatty acids are converted to form the important, highly unsaturated, 
long-chained AA, EPA and DHA. 
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Figure 4.4 Synthesis of AA and DHA from essential fatty acids. Abbreviations 
are as follow: LA: linoleic acid; GLA, gamma-linolinolenic acid; DGLA, 
dihomogammalinolenic acid; AA, arachidonic acid, ALA, alpha-linolenic acid; EPA, 
eicosapenlanoic acid (Haag, 2003). 
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When looking into the cellular energy metabolism pathway involving glucose 
and fatty acids (Figure 4.3), synthesis of fatty acids requires malonyl-CoA, and 
synthesis of malonyl-CoA requires acetyl-CoA，and glucose is the source of 
acetyl-CoA. The decrease in glucose concentration will probably affect the 
provision of substrate for fatty acids synthesis in the in vitro system. As stated 
before, fatty acids will undergo beta-oxidation for ketone bodies synthesis and 
serves as an energy substrate for neurons. Therefore, we studied the mRNA 
expression of FASN and HMGCS2. FASN is a key metabolic enzyme catalysing 
the synthesis of long chain saturated fatty acids. This complex is responsible for 
the elongation of fatty acid chains by adding acetyl groups donated by maonyl-CoA. 
We also studied the fatty acid profile in media and in cells to investigate the effects 
of glucose deficiency on fatty acid components in these cells. 
Interestingly, our data showed that FASN was up-regulated when glucose 
concentration decreased in both C6 cells and astrocytes. This observation might 
imply the increase in synthetic rate of fatty acids in these cells. Complementary to 
the up regulation of FASN in C6 cells, the total fatty acids of C6 cells have increased 
significantly in media and in cells, and the response was serum independent. The 
profile of fatty acid was affected too. 
By contrast, primary astrocytes did not show an increase in fatty acid quantities 
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in media or in cells. There was no significant difference amongst different groups 
with different glucose concentrations in media or cells. This result showed that 
even though decreased glucose would up-regulate FASN in primary astrocytes, there 
was no effect on the total quantities of fatty acids. In short, there was a change in 
the fatty acid profile when glucose concentration was changed. 
Although C6 cells produced more fatty acid while astrocytes did not when 
glucose concentration decreased, the change of fatty acid profiles are similar in the 
two cell types. The data showed that there are only three FA significantly altered in 
C6 cells while primary astrocytes have given the similar trend of increase for these 
fatty acids, including AA, arachidic acid and DHA. Although AA was not 
detectable in the group of the media without serum of C6 cells, AA was detectable in 
other data group and showed significant increases when glucose level decreased. 
The effect was serum independent because AA was increased when glucose 
decreased whenever serum was added or not. Although the data here showed no 
significant difference amongst the treatment groups with different glucose 
concentrations, there was a similar trend. The trend showed that the release of AA 
was glucose concentration dependent. Interestingly, accumulation of AA in the 
cerebral cortex under severe hypoglycemia state was also reported in previous in 
vivo stuties (Agardh， 1980; Visioli et al.’ 1993). Therefore， the present data 
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showed that decrease in glucose concentration alone could already induce 
accumulation of AAin glial cells. 
Free AA plays multiple signaling roles in the CNS. First of all，AA is a 
facilitatory retrograde messenger in hippocampal glutamatergic synapses because 
the increase of exogenous or endogenous AA increases the basal outflow and the 
K+-evoked release of GABA from rat hippocampal synaptosomes (Cunha and 
Ribeiro，1999). Also, AA is a precursor of prostaglandins which regulate 
glutamatergic cross-talk between neurons and astrocytes (Bezzi et al., 1998). The 
conversion of AA to prostaglandins is particularly active in astrocytes with enzymes, 
cyclooxygenases (COXs) (O'Banion et al., 1996). When neurons are activated, 
they release glutamate. The glutamate will activate the postsynaptic neurons and 
nearby astrocytes. Activated astrocytes then elevate the intracellular Ca^ "^  mediated 
by prostaglandin. Following the elevated astrocytic Ca^^, astrocyte release 
glutamate and start the back-signaling to neurons causing an increase of Ca^^ in 
neurons (Bazan, 2003). In addition, the COX-2 that is specific for the production 
of prostaglandins E2 (PGE2) can produce activity-dependent synaptic plasticity via 
the synthesis of PGE2 (Brock et al., 1999). It is because the PGE2 acts on the 
neuronal PGE2 receptor and regulates membrane excitability and the LTP (Gold et 
al., 1998; Ingram and Williams, 1996; Nicol et al., 1997). Furthermore, PGE2 is 
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an important inflammatory mediator and may engage in neuroprotective mechanism. 
It was reported that exogenous PGE2 protected against neuronal apoptotic cell death 
associated with inflammatory neurotoxicity through the intracellular cAMP system. 
The mechanism is associated with the modulation of nitric oxide from microglial 
cells and reactive oxygen species production from neurons (Kim et al., 2002). 
In the current studies, the data showed that decreased glucose concentration 
increased AA released from glia cell; so, a decrease in glucose concentration may 
modulate the LTP and glutamatergic communication between astrocytes and neurons 
and increase neuroprotective effect to neurons by inhibiting apoptosis via increasing 
PGE2 and prostaglandin production. 
Although omega 3 fatty acid constitute the highest quantities of unsaturated 
fatty acids in the brain (Bruder et al., 2004)，due to the insufficient supplies of 
precursors for omega 3 fatty acids synthesis, DHA in the cells and media was very 
low and EPA was even undetectable. Although not significant, increasing trends of 
cellular DHA quantities in both cell types were observed when glucose 
concentration decreased. The fact that the difference of DHA values became 
insufficient significant between treatments is due to the small value relative to 
standard deviation. Due to the important multiple roles played by DHA in the CNS 
(Calon et aL, 2004)，the trends consistently observed in C6 cells and primary 
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astrocytes might be a specific response of glial cells. DHA is a major 
polyunsaturated fatty acid in the CNS and the liver is the major supplier of DHA in 
the body. DHA is synthesized from linolenic acid (Figure 6.2) and is transported 
by VLDLs (Scott and Bazan, 1989). It participates in cell function and in 
neurodegenerations. For example, during brain ischemia-reperfusion, lipid 
peroxidation occurs (Beal，1996). DHA-containing phospholipids are a target for 
lipid peroxidation (Bazan, 1970). The DHA-oxygenation leads to the formation of 
two messengers, 10,17S-docosatriene and resolving-type messengers (Marcheselli et 
aL, 2003). The messengers exert counter-regulatory actions to depress 
proinflammatory signals (Serhan et aL, 2002; Serhan et aL, 2000; Hong et al., 2003). 
As a result, the messengers have neuroprotective effect on brain damage 
(Marcheselli et al., 2003). In our studies, the decreased glucose concentration 
initiated an increase in cellular DHA that indicated an increase in DHA-containing 
phospholipids on the membrane. The increased quantities of DHA would lead to 
an increase in 10,17S-docosatriene and the production of resolving-type messengers. 
Therefore, glucose depletion may potentiate the neuroprotective effect of glial cells 
against oxidation damages initiated by energy failure. 
Arachidic acid was one of the fatty acids that increased in quantities when 
glucose level decreased. However, data regarding the effects of this saturated fatty 
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acid on the CNS was not well studied. Instead, previous studies showed that 
emulsions containing long chain saturated fatty acid but not medium chain fatty acid 
activate human neurophils to increase the production of oxygen radical (Wanten et 
al., 1999; Kruimel et al., 2000). Furthermore, the neurophils also increase oxygen 
radical after the addition of dissolved arachidic acid (Wanten et al., 2002). As 
arachidic acid can modulate the immunoreactivity in the peripheral tissues, this fatty 
acid might probably have similar effects in the other tissues including the CNS that 
require further studies. 
4.4.4 Decreased Ketone Body Synthesis in Glucose Deficiency 
Since the fatty acid synthesis is affected by the change in glucose concentration, the 
ketone body production may also be altered. HMGCS2 is another HMG-CoA 
synthase located in the mitochondria (Figure 4.3). HMG-CoA produced by 
HMGCS2 is transformed into acetoacetate by the action of HMG-CoA lyase. 
Acetoacetate is transformed into hydroxybutyrate and acetone that are known as 
ketone bodies. The ketone bodies produced by astrocytic mitochondria are 
exported for neuronal utilization as energy substrates. HMGCS2 is the rate 
limiting enzyme of the ketogenic pathway (Williamson, et al., 1968; Dashti and 
Ontko, 1979). Here we have demonstrated that when glucose supply to C6 cells 
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and primary astrocytes decreased, the critical enzyme in ketogenesis was 
down-regulated. The ketogenesis activity might also be decreased. Therefore, 
hypoglycorhachia induced by insulin treatment and GlutlDS might cause the 
depletion of ketone bodies supply to neurons provided by astrocytes eventhough 
there was an increase in total cellular fatty acid quantities. 
4.5 Limitations of the Current Study 
The in vitro models used in this project have certain limitations. (1) C6 is a 
glioma cell line and may respond to the treatment differently from non-cancer cells. 
(2) Although primary astrocytes were used in the current study, glucose plays a 
critical role in cross-talk between glials and neurons; the absence of neurons in our 
model thus could not fully reflect the situation in vivo. Responses of neurons under 
glucose deficiency were not considered in the current study. (3) The C6 cells and 
primary asctorcytes used in the project were derived from rats. Although rats and 
human share significant genetic similarity, the response of rat cells still cannot fully 
represent the responses of human cells. 
There are limitations in the studies of neurotrophins expression. (1) The 
probes used for northern blot assays were complementary to the coding regions. 
Although more than one transcripts were detected in BDNF and NT-3, the identities 
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of promoter of each transcripts cannot be identified. Therefore, the study of the 
relationship of glucose concentration and regulation of neurotrophin expression was 
limited. (2) Neurotrophins are secretary proteins. Since we did not monitor 
secretion of neurotrophins into the media, the discrepancies of the change of mRNA 
expression levels to the protein expression levels of various neurotrophins might be 
caused by the secretion of target proteins to the media. 
In the studies of lipid homeostasis, the omega-3 fatty acids were too low. It 
was due to the absence of the precursors for the synthesis of the omega-3 fatty acids 
in the media. Although FBS contains small amount of fatty acids, only 11% of 
total fatty acid is omege-3 fatty acids while 16.7% is monounsaturated fatty acid, 
13.9% is omega-6 fatty acids and 56% is saturated fatty acid present in the raw FBS 
(Champeil-Potokar et al.，2004). Omega-3 fatty acids were present in the smallest 
amount. Therefore, the EPA and DHA quantities were too low to be detected or to 
reach a significant level of differences between treatment groups. 
4.6 Future Directions 
Previous experiments showed that ApoE act as an important immunomodulator 
(Avila et al.’ 1982; Pepe and Curtiss, 1986; Curtiss and Edgington, 1981; Lynch et 
aL, 2003). As we have found that glucose deficiency induced ApoE expression, 
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this increases the possibility that cytokine production such as TNF-a and 
interlukines (Lynch et al., 2003) will be changed. In addition, the increase of AA 
production in the glial cells may be due to the activation of interlukine-lB 
(O'Banion et al., 1996). Therefore, cytokines production should be studied. 
The data here show that there is an increase in cholesterol content as well as 
expression of ApoE mRNA in C6 cells when glucose concentration decreased. In 
order to determined whether the increased cholesterol are being co-secreted with 
apoE or other apolipoprotein as lipoprotein particles, non-denaturing gradient gel 
electrophoresis followed by western blotting for detection of apoE should be 
preformed (Wahrle et al., 2004). 
In the future, siRNA technique can be employed to study the effect of 
intracellular glucose deficiency. This could be achieved by introducing a siRNA 
expression vector targeting to the mRNA of GLUTl in order to decrease the protein 
expression of Glutl. Under this condition, glucose uptake becomes the limiting 
factor for glucose metabolism in cells and this can serve as a better cellular model 
for studying the GLUTIDS condition. 
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Chapter 5 Conclusion 
Glucose deficiency does not cause an overall down-regulation of cell 
proliferation or production of neurotrophic factors. Instead, glial cells modify their 
neurotrophic strategies in a pathway and gene-specific manner in response to 
glucose deficiency by differential regulation of the lipid and neurotrophic factor 
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Figure A.1 Trypan blue viability test of C6 cells grown in different glucose 
concentrations. C6 cells (5,000 cells/well) were seeded in 24-well plates in 
complete media. After 24 hours，cells underwent serum starvation with 0.1% FBS 
for 48 hours. On day 0, cells were washed with IX PBS twice and incubated in 1， 
2 and 3 mM glucose media. Cell were resuspended in 100 PBS and stained by 
adding 100 of 0.4% trypan blue solution for five minutes. Ceils stained in blue 
represent death cell while unstained represent viable. Number of unstained / total 
number of cells x 100% represented the percentage of viable cells. Data were 
expressed as mean 土 SEM of a quadruplican setup. *'represents significant 
difference between 1 and 3 mM (p<0.05), ‘#’ represents significant difference 
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